Cancer Pathology Data Sharing, published by HL7 International / Orders and Observations. This guide is not an authorized publication; it is the continuous build for version 2.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/cancer-reporting/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: US Pathology Exchange bundle example - XML Representation

Raw xml | Download

<Bundle xmlns="http://hl7.org/fhir">
  <id value="bundle-us-pathology-exchange"/>
  <meta>
    <profile
             value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-bundle"/>
  </meta>
  <identifier>
    <system value="urn:ietf:rfc:3986"/>
    <value value="urn:uuid:1e518c9a-b9a2-4ee6-a350-8965b7924311"/>
  </identifier>
  <type value="document"/>
  <timestamp value="2024-12-05T18:05:57.689+00:00"/>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Composition/composition-invasive-carcinoma-of-the-breast"/>
    <resource>
      <Composition>
        <id value="composition-invasive-carcinoma-of-the-breast"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-composition"/>
        </meta>
        <text>
          <status value="extensions"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Composition_composition-invasive-carcinoma-of-the-breast"> </a><p class="res-header-id"><b>Generated Narrative: Composition composition-invasive-carcinoma-of-the-breast</b></p><a name="composition-invasive-carcinoma-of-the-breast"> </a><a name="hccomposition-invasive-carcinoma-of-the-breast"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-composition.html">US Pathology Composition Laboratory Report</a></p></div><p><b>Document DiagnosticReport Reference</b>: <a href="DiagnosticReport-diagnosticreport-breast-invasive-carcinoma.html">Diagnostic Report for 'Pathology Synoptic report' for '-&gt;Annie Oakley'</a></p><p><b>status</b>: Final</p><p><b>type</b>: <span title="Codes:{http://cap.org/eCC Breast.Invasive.Res.189_4.009.021.REL_sdcFDF}">INVASIVE CARCINOMA OF THE BREAST: Biopsy</span></p><p><b>encounter</b>: <a href="Bundle-bundle-us-pathology-exchange.html#http-//hl7.org/fhir/us/cancer-reporting/Encounter/encounter-uspath-specimen-collection">Bundle: identifier = UUID:1e518c9a-b9a2-4ee6-a350-8965b7924311; type = document; timestamp = 2024-12-05 18:05:57+0000</a></p><p><b>date</b>: 2025-01-01 21:39:30+0000</p><p><b>author</b>: <a href="PractitionerRole-practitionerrole-uspath-practitioner-oncologist.html">Wise Owl</a></p><p><b>title</b>: INVASIVE CARCINOMA OF THE BREAST: Resection</p></div>
        </text>
        <extension
                   url="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/composition-diagnosticReportReference">
          <valueReference>🔗 
            <reference
                       value="DiagnosticReport/diagnosticreport-breast-invasive-carcinoma"/>
          </valueReference>
        </extension>
        <status value="final"/>
        <type>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="Breast.Invasive.Res.189_4.009.021.REL_sdcFDF"/>
            <display value="INVASIVE CARCINOMA OF THE BREAST: Biopsy"/>
          </coding>
        </type>
        <subject>🔗 
          <reference
                     value="http://hl7.org/fhir/us/cancer-reporting/Patient/patient-OakleyAnnie"/>
          <display value="Annie Oakley"/>
        </subject>
        <encounter>🔗 
          <reference
                     value="http://hl7.org/fhir/us/cancer-reporting/Encounter/encounter-uspath-specimen-collection"/>
        </encounter>
        <date value="2025-01-01T21:39:30.000Z"/>
        <author>🔗 
          <reference
                     value="PractitionerRole/practitionerrole-uspath-practitioner-oncologist"/>
          <display value="Wise Owl"/>
        </author>
        <title value="INVASIVE CARCINOMA OF THE BREAST: Resection"/>
        <section>
          <title value="INVASIVE CARCINOMA OF THE BREAST: Resection"/>
          <code>
            <coding>
              <system value="http://loinc.org"/>
              <code value="26436-6"/>
              <display value="Laboratory Studies (set)"/>
            </coding>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml"><p><b>Specimen</b></p><p><b>Procedure</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">✓</span> Needle biopsy<br/><span style="display: inline-block; width: 20px;">__</span> Fine needle aspiration<br/><span style="display: inline-block; width: 20px;">__</span> Other (specify): ___________________<br/><span style="display: inline-block; width: 20px;">__</span> Not specified</p><p><b>Specimen Laterality</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">__</span> Right<br/><span style="display: inline-block; width: 20px;">✓</span> Left<br/><span style="display: inline-block; width: 20px;">__</span> Not specified</p><p><b>+Tumor Site (select all that apply)</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">__</span> Upper outer quadrant<br/><span style="display: inline-block; width: 20px;">__</span> Lower outer quadrant<br/><span style="display: inline-block; width: 20px;">__</span> Upper inner quadrant<br/><span style="display: inline-block; width: 20px;">__</span> Lower inner quadrant<br/><span style="display: inline-block; width: 20px;">__</span> Central<br/><span style="display: inline-block; width: 20px;">__</span> Nipple<br/><span style="display: inline-block; width: 20px;">✓</span> Clock position</p><p style="margin-left: 40px;"><b>Specify Clock Position (select all that apply)</b></p><p style="margin-left: 60px;"><span style="display: inline-block; width: 20px;">__</span> 1 o'clock<br/><span style="display: inline-block; width: 20px;">__</span> 2 o'clock<br/><span style="display: inline-block; width: 20px;">__</span> 3 o'clock<br/><span style="display: inline-block; width: 20px;">__</span> 4 o'clock<br/><span style="display: inline-block; width: 20px;">__</span> 5 o'clock<br/><span style="display: inline-block; width: 20px;">__</span> 6 o'clock<br/><span style="display: inline-block; width: 20px;">__</span> 7 o'clock<br/><span style="display: inline-block; width: 20px;">✓</span> 8 o'clock<br/><span style="display: inline-block; width: 20px;">__</span> 9 o'clock<br/><span style="display: inline-block; width: 20px;">__</span> 10 o'clock<br/><span style="display: inline-block; width: 20px;">__</span> 11 o'clock<br/><span style="display: inline-block; width: 20px;">__</span> 12 o'clock</p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">__</span> Specify distance from nipple in Centimeters (cm): _______________ cm<br/><span style="display: inline-block; width: 20px;">__</span> Other (specify): ___________________<br/><span style="display: inline-block; width: 20px;">__</span> Not specified</p><p><b>Histologic Type (Note A)</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">__</span> No residual invasive carcinoma<br/><span style="display: inline-block; width: 20px;">✓</span> Invasive carcinoma of no special type (ductal)<br/><span style="display: inline-block; width: 20px;">__</span> Micro-invasive carcinoma<br/><span style="display: inline-block; width: 20px;">__</span> Invasive lobular carcinoma<br/><span style="display: inline-block; width: 20px;">__</span> Invasive carcinoma with mixed ductal and lobular features<br/><span style="display: inline-block; width: 20px;">__</span> Invasive carcinoma with features of (specify): ___________________<br/><span style="display: inline-block; width: 20px;">__</span> Tubular carcinoma<br/><span style="display: inline-block; width: 20px;">__</span> Invasive cribriform carcinoma<br/><span style="display: inline-block; width: 20px;">__</span> Mucinous carcinoma<br/><span style="display: inline-block; width: 20px;">__</span> Invasive micropapillary carcinoma<br/><span style="display: inline-block; width: 20px;">__</span> Apocrine adenocarcinoma<br/><span style="display: inline-block; width: 20px;">__</span> Metaplastic carcinoma<br/><span style="display: inline-block; width: 20px;">__</span> Encapsulated papillary carcinoma with invasion<br/><span style="display: inline-block; width: 20px;">__</span> Solid papillary carcinoma with invasion<br/><span style="display: inline-block; width: 20px;">__</span> Intraductal papillary adenocarcinoma with invasion<br/><span style="display: inline-block; width: 20px;">__</span> Adenoid cystic carcinoma<br/><span style="display: inline-block; width: 20px;">__</span> Neuroendocrine tumor<br/><span style="display: inline-block; width: 20px;">__</span> Neuroendocrine carcinoma<br/><span style="display: inline-block; width: 20px;">__</span> Invasive carcinoma, type cannot be determined: ___________________<br/><span style="display: inline-block; width: 20px;">__</span> Other histologic type not listed (specify): ___________________<br/><span style="display: inline-block; width: 20px;">__</span> Histologic Type Comment: ___________________</p><p><b>Histologic Grade (Nottingham Histologic Score) (required only if applicable) (Note B)</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">__</span> Not applicable (no residual carcinoma or microinvasion only)<br/><span style="display: inline-block; width: 20px;">✓</span> Nottingham Score</p><p style="margin-left: 40px;"><b>Glandular (Acinar) / Tubular Differentiation</b></p><p style="margin-left: 60px;"><span style="display: inline-block; width: 20px;">✓</span> Score 1 (greater than 75% of tumor area forming glandular / tubular structures)<br/><span style="display: inline-block; width: 20px;">__</span> Score 2 (10% to 75% of tumor area forming glandular / tubular structures)<br/><span style="display: inline-block; width: 20px;">__</span> Score 3 (less than 10% of tumor area forming glandular / tubular structures)<br/><span style="display: inline-block; width: 20px;">__</span> Score cannot be determined</p><p style="margin-left: 40px;"><b>Nuclear Pleomorphism</b></p><p style="margin-left: 60px;"><span style="display: inline-block; width: 20px;">__</span> Score 1 (Nuclei small with little increase in size in comparison with normal breast epithelial cells, regular outlines, uniform nuclear chromatin, little variation in size)<br/><span style="display: inline-block; width: 20px;">✓</span> Score 2 (Cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate variability in both size and shape)<br/><span style="display: inline-block; width: 20px;">__</span> Score 3 (Vesicular nuclei, often with prominent nucleoli, exhibiting marked variation in size and shape, occasionally with very large and bizarre forms)<br/><span style="display: inline-block; width: 20px;">__</span> Score cannot be determined</p><p style="margin-left: 40px;"><b>Mitotic Rate</b></p><p style="margin-left: 60px;"><span>See Table 1 in <i>CAP Protocol</i></span><br/><span style="display: inline-block; width: 20px;">✓</span> Score 1<br/><span style="display: inline-block; width: 20px;">__</span> Score 2<br/><span style="display: inline-block; width: 20px;">__</span> Score 3<br/><span style="display: inline-block; width: 20px;">__</span> Score cannot be determined: ___________________</p><p style="margin-left: 40px;"><b>Overall Grade</b></p><p style="margin-left: 60px;"><span style="display: inline-block; width: 20px;">✓</span> Grade 1 (scores of 3, 4, or 5)</p><p><b>Tumor Size (Note E)</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">__</span> No residual invasive carcinoma<br/><span style="display: inline-block; width: 20px;">__</span> Microinvasion only (less than or equal to 1 mm)<br/><span style="display: inline-block; width: 20px;">✓</span> Greatest dimension of largest invasive focus greater than 1 mm (specify exact measurement in Millimeters (mm)): <b>13.0</b> mm<br/><span style="display: inline-block; width: 20px;">__</span> Additional Dimension in Millimeters (mm): ____ × ____ mm<br/><span style="display: inline-block; width: 20px;">__</span> Size of largest invasive focus cannot be determined (explain): ___________________</p><p><b>+Tumor Focality (Note F)</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">✓</span> Single focus of invasive carcinoma<br/><span style="display: inline-block; width: 20px;">__</span> Multiple foci of invasive carcinoma<br/><span style="display: inline-block; width: 20px;">__</span> Number of Foci<br/><span style="display: inline-block; width: 20px;">__</span> Specify number: ___________________<br/><span style="display: inline-block; width: 20px;">__</span> At least: ___________________<br/><span style="display: inline-block; width: 20px;">__</span> Cannot be determined</p><p><b>Ductal Carcinoma In Situ (DCIS) (Note G)</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">✓</span> Not identified<br/><span style="display: inline-block; width: 20px;">__</span> Present<br/><span style="display: inline-block; width: 20px;">__</span> Present (in close proximity to invasive carcinoma)<br/><span style="display: inline-block; width: 20px;">__</span> Present only after presurgical therapy and prior to therapy the cancer is classified as pTis<br/><span style="display: inline-block; width: 20px;">__</span> Negative for extensive intraductal component (EIC)<br/><span style="display: inline-block; width: 20px;">__</span> Positive for extensive intraductal component (EIC)<br/><span style="display: inline-block; width: 20px;">__</span> Only DCIS is present after presurgical (neoadjuvant) therapy</p><p><b>+Size (Extent) of DCIS</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">__</span> Estimated size (extent) of DCIS is at least in Millimeters (mm): _____ mm<br/><span style="display: inline-block; width: 20px;">__</span> Additional Dimension in Millimeters (mm): _____ × _____ mm<br/><span style="display: inline-block; width: 20px;">__</span> Cannot be determined</p><p><b>Tumor Extent (Note H)</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">__</span> Tumor Extent (required only if skin, nipple, or skeletal muscle are present and involved) (select all that apply)<br/><span style="display: inline-block; width: 20px;">✓</span> Not applicable (skin, nipple, and skeletal muscle are absent OR are uninvolved)</p><p><b>Margin Status for Invasive Carcinoma (required only if residual invasive carcinoma is present in specimen)</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">__</span> Not applicable (residual invasive carcinoma in specimen is absent)<br/><span style="display: inline-block; width: 20px;">✓</span> All margins negative for invasive carcinoma</p><p><b>Distance from Invasive Carcinoma to Closest Margin</b></p><p style="margin-left: 20px;"><span>Specify in Millimeters (mm):</span></p><p style="margin-left: 40px;"><span style="display: inline-block; width: 20px;">✓</span> Exact distance: ______________ mm<br/><span style="display: inline-block; width: 20px;">__</span> Less than: ______________ mm<br/><span style="display: inline-block; width: 20px;">__</span> Greater than: ______________ mm<br/><span style="display: inline-block; width: 20px;">__</span> Other (specify): ______________<br/><span style="display: inline-block; width: 20px;">__</span> Cannot be determined (explain): ______________</p><p><b>+Closest Margin(s) to Invasive Carcinoma (select all that apply)</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">__</span> Anterior<br/><span style="display: inline-block; width: 20px;">__</span> Posterior<br/><span style="display: inline-block; width: 20px;">__</span> Superior<br/><span style="display: inline-block; width: 20px;">__</span> Inferior<br/><span style="display: inline-block; width: 20px;">__</span> Medial<br/><span style="display: inline-block; width: 20px;">✓</span> Lateral<br/><span style="display: inline-block; width: 20px;">__</span> Other (specify): ______________<br/><span style="display: inline-block; width: 20px;">__</span> Cannot be determined (explain): ______________</p><p><b>Margin(s) Involved by Invasive Carcinoma (select all that apply)</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">__</span> Anterior (specify extent): ______________<br/><span style="display: inline-block; width: 20px;">__</span> Posterior (specify extent): ______________<br/><span style="display: inline-block; width: 20px;">__</span> Superior (specify extent): ______________<br/><span style="display: inline-block; width: 20px;">__</span> Inferior (specify extent): ______________<br/><span style="display: inline-block; width: 20px;">__</span> Medial (specify extent): ______________<br/><span style="display: inline-block; width: 20px;">__</span> Lateral (specify extent): ______________<br/><span style="display: inline-block; width: 20px;">__</span> Other (specify margin(s) and extent): ______________<br/><span style="display: inline-block; width: 20px;">__</span> Cannot be determined (explain): ______________<br/><span style="display: inline-block; width: 20px;">__</span> Other (specify): ______________<br/><span style="display: inline-block; width: 20px;">__</span> Cannot be determined (explain): ______________</p><p><b>Regional Lymph Node Status</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">__</span> Not applicable (no regional lymph nodes submitted or found)<br/><span style="display: inline-block; width: 20px;">✓</span> Regional lymph nodes present<br/><span style="display: inline-block; width: 20px;">__</span> All regional lymph nodes negative for tumor<br/><span style="display: inline-block; width: 20px;">__</span> Tumor present in regional lymph node(s)</p><p><b>Number of Lymph Nodes with Macrometastases (greater than 2 mm)</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">__</span> Exact number (specify): ______________<br/><span style="display: inline-block; width: 20px;">__</span> At least (specify): ______________<br/><span style="display: inline-block; width: 20px;">__</span> Other (specify): ______________<br/><span style="display: inline-block; width: 20px;">__</span> Cannot be determined (explain): ______________</p><p><b>Number of Lymph Nodes with Micrometastases (greater than 0.2 mm to 2 mm and / or greater than 200 cells)</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">__</span> Exact number (specify): ______________<br/><span style="display: inline-block; width: 20px;">__</span> At least (specify): ______________<br/><span style="display: inline-block; width: 20px;">__</span> Other (specify): ______________<br/><span style="display: inline-block; width: 20px;">__</span> Cannot be determined (explain): ______________</p><p><b>Number of Lymph Nodes with Isolated Tumor Cells (0.2 mm or less OR 200 cells or less) (required only if applicable)</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">__</span> Not applicable<br/><span style="display: inline-block; width: 20px;">__</span> Exact number (specify): ______________<br/><span style="display: inline-block; width: 20px;">__</span> At least (specify): ______________<br/><span style="display: inline-block; width: 20px;">__</span> Other (specify): ______________<br/><span style="display: inline-block; width: 20px;">__</span> Cannot be determined (explain): ______________</p><p><b>Size of Largest Nodal Metastatic Deposit</b></p><p style="margin-left: 20px;"><span>Specify in Millimeters (mm):</span></p><p style="margin-left: 40px;"><span style="display: inline-block; width: 20px;">__</span> Exact size: ______________ mm<br/><span style="display: inline-block; width: 20px;">__</span> Less than: ______________ mm<br/><span style="display: inline-block; width: 20px;">__</span> Greater than: ______________ mm<br/><span style="display: inline-block; width: 20px;">__</span> Other (specify): ______________<br/><span style="display: inline-block; width: 20px;">__</span> Cannot be determined (explain): ______________</p><p><b>Extranodal Extension</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">__</span> Not identified<br/><span style="display: inline-block; width: 20px;">__</span> Present, 2 mm or less<br/><span style="display: inline-block; width: 20px;">__</span> Present, greater than 2 mm</p><p style="margin-left: 20px;"><b>+Specify Amount:</b></p><p style="margin-left: 40px;"><span style="display: inline-block; width: 20px;">__</span> Present<br/><span style="display: inline-block; width: 20px;">__</span> Cannot be determined: ______________<br/><span style="display: inline-block; width: 20px;">__</span> Other (specify): ______________<br/><span style="display: inline-block; width: 20px;">__</span> Cannot be determined (explain): ______________</p><p><b>Total Number of Lymph Nodes Examined (sentinel and non-sentinel)</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">✓</span> Exact number (specify): ______________<br/><span style="display: inline-block; width: 20px;">__</span> At least (specify): ______________<br/><span style="display: inline-block; width: 20px;">__</span> Other (specify): ______________<br/><span style="display: inline-block; width: 20px;">__</span> Cannot be determined (explain): ______________</p><p><b>Number of Sentinel Nodes Examined (if applicable)</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">__</span> Not applicable<br/><span style="display: inline-block; width: 20px;">✓</span> Exact number (specify): ______________<br/><span style="display: inline-block; width: 20px;">__</span> At least (specify): ______________<br/><span style="display: inline-block; width: 20px;">__</span> Other (specify): ______________<br/><span style="display: inline-block; width: 20px;">__</span> Cannot be determined (explain): ______________</p><p><b>Distant Site(s) Involved, if applicable (select all that apply)</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">✓</span> Not applicable<br/><span style="display: inline-block; width: 20px;">__</span> Non-regional lymph node(s) (specify, if possible): ______________<br/><span style="display: inline-block; width: 20px;">__</span> Lung: ______________<br/><span style="display: inline-block; width: 20px;">__</span> Liver: ______________<br/><span style="display: inline-block; width: 20px;">__</span> Bone: ______________<br/><span style="display: inline-block; width: 20px;">__</span> Brain: ______________<br/><span style="display: inline-block; width: 20px;">__</span> Other (specify): ______________<br/><span style="display: inline-block; width: 20px;">__</span> Cannot be determined</p><p><b>Modified Classification (required only if applicable) (select all that apply)</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">__</span> Not applicable<br/><span style="display: inline-block; width: 20px;">__</span> y (post-neoadjuvant therapy)<br/><span style="display: inline-block; width: 20px;">__</span> r (recurrence)</p><p><b>pT Category</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">__</span> pT not assigned (cannot be determined based on available pathological information)<br/><span style="display: inline-block; width: 20px;">__</span> pT0: No evidence of primary tumor<br/><span style="display: inline-block; width: 20px;">__</span> pTis (DCIS): Ductal carcinoma in situ<br/><span style="display: inline-block; width: 20px;">__</span> pTis (Paget): Paget disease NOT associated with invasive carcinoma and / or carcinoma in situ (DCIS) in the underlying breast parenchyma<br/><span style="display: inline-block; width: 20px;">__</span> pT1: Tumor less than or equal to 20 mm in greatest dimension<br/><span style="display: inline-block; width: 20px;">__</span> pT1mi: Tumor less than or equal to 1 mm in greatest dimension<br/><span style="display: inline-block; width: 20px;">__</span> pT1a: Tumor greater than 1 mm but less than or equal to 5 mm in greatest dimension<br/><span style="display: inline-block; width: 20px;">✓</span> pT1b: Tumor greater than 5 mm but less than or equal to 10 mm in greatest dimension<br/><span style="display: inline-block; width: 20px;">__</span> pT1c: Tumor greater than 10 mm but less than or equal to 20 mm in greatest dimension<br/><span style="display: inline-block; width: 20px;">__</span> pT2: Tumor greater than 20 mm but less than or equal to 50 mm in greatest dimension<br/><span style="display: inline-block; width: 20px;">__</span> pT3: Tumor greater than 50 mm in greatest dimension<br/><span style="display: inline-block; width: 20px;">__</span> pT4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules)<br/><span style="display: inline-block; width: 20px;">__</span> pT4a: Extension to the chest wall; invasion of or adherence to pectoralis muscle in the absence of invasion of chest wall structures does not qualify as T4<br/><span style="display: inline-block; width: 20px;">__</span> pT4b: Ulceration and/or ipsilateral satellite nodules and/or edema (including peau d'orange) of the skin which do not meet the criteria for inflammatory carcinoma<br/><span style="display: inline-block; width: 20px;">__</span> pT4c: Both T4a and T4b are present<br/><span style="display: inline-block; width: 20px;">__</span> pT4d: Inflammatory carcinoma<br/><span style="display: inline-block; width: 20px;">__</span> pT4 (subcategory cannot be determined)</p><p><b>pN Category</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">__</span> pN not assigned (no nodes submitted or found)<br/><span style="display: inline-block; width: 20px;">__</span> pN not assigned (cannot be determined based on available pathological information)<br/><span style="display: inline-block; width: 20px;">✓</span> pN0: No regional lymph node metastasis identified or ITCs only<br/><span style="display: inline-block; width: 20px;">__</span> pN0 (i+): ITCs only (malignant cell clusters no larger than 0.2 mm) in regional lymph node(s)<br/><span style="display: inline-block; width: 20px;">__</span> pN0 (mol+): Positive molecular findings by reverse transcriptase polymerase chain reaction (RT-PCR); no ITCs detected<br/><span style="display: inline-block; width: 20px;">__</span> pN1: Metastases in 1 to 3 axillary lymph nodes, at least one metastasis larger than 2.0 mm<br/><span style="display: inline-block; width: 20px;">__</span> pN1mi: Micrometastases (approximately 200 cells, larger than 0.2 mm, but none larger than 2.0 mm)<br/><span style="display: inline-block; width: 20px;">__</span> pN1a: Metastases in 1 to 3 axillary lymph nodes, at least one metastasis larger than 2.0 mm<br/><span style="display: inline-block; width: 20px;">__</span> pN1b: Metastases in internal mammary sentinel nodes, excluding ITCs<br/><span style="display: inline-block; width: 20px;">__</span> pN1c: pN1a and pN1b combined<br/><span style="display: inline-block; width: 20px;">__</span> pN2: Metastases in 4-9 axillary lymph nodes; or in clinically detected internal mammary lymph nodes with negative axillary nodes<br/><span style="display: inline-block; width: 20px;">__</span> pN2a: Metastases in 4-9 axillary lymph nodes (at least one tumor deposit larger than 2.0 mm)<br/><span style="display: inline-block; width: 20px;">__</span> pN2b: Metastases in clinically detected internal mammary lymph nodes with or without microscopic confirmation; with pathologically negative axillary lymph nodes<br/><span style="display: inline-block; width: 20px;">__</span> pN3: Metastases in 10 or more axillary lymph nodes; or in infraclavicular (level III axillary) lymph nodes; or in clinically detected ipsilateral internal mammary lymph nodes with one or more positive level I, II axillary lymph nodes; or in more than 3 axillary lymph nodes and in internal mammary lymph nodes with microscopic disease or macroscopic disease detected by sentinel lymph node biopsy but not clinically detected; or in ipsilateral supraclavicular lymph nodes<br/><span style="display: inline-block; width: 20px;">__</span> pN3a: Metastases in 10 or more axillary lymph nodes (at least one tumor deposit larger than 2.0 mm); or metastases to the infraclavicular (level III axillary lymph) nodes<br/><span style="display: inline-block; width: 20px;">__</span> pN3b: pN1a or pN2a in the presence of cN2b (positive internal mammary nodes by imaging); or pN2a in the presence of pN1b<br/><span style="display: inline-block; width: 20px;">__</span> pN3c: Metastases in ipsilateral supraclavicular lymph nodes</p><p><b>N Suffix (required only if applicable)</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">__</span> Not applicable<br/><span style="display: inline-block; width: 20px;">__</span> (sn) Sentinel node(s) evaluated. If 6 or more nodes (sentinel or nonsentinel) are removed, this modifier should not be used<br/><span style="display: inline-block; width: 20px;">__</span> (f) Nodal metastasis confirmed by fine needle aspiration or core needle biopsy<br/><span style="display: inline-block; width: 20px;">__</span> (m) Multiple primary synchronous tumors in a single organ</p><p><b>ADDITIONAL FINDINGS (Note O)</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">+</span>Additional Findings (specify): ________________</p><p><b>SPECIAL STUDIES</b></p><p style="margin-left: 20px;">The CAP Breast Biomarker Template should be used for reporting biomarkers requested for this resection specimen. Pending biomarker studies should be listed in the Comments section of this report.</p><p><b>+Breast Biomarker Studies Performed on Previous Biopsy (select all that apply)</b></p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">✓</span> Estrogen Receptor (ER)</p><p style="margin-left: 40px;"><b>Estrogen Receptor (ER) Status</b></p><p style="margin-left: 60px;"><span style="display: inline-block; width: 20px;">__</span> Positive (greater than 10% of cells demonstrate nuclear positivity)<br/><span style="display: inline-block; width: 20px;">__</span> Low Positive (1-10% of cells with nuclear positivity)<br/><span style="display: inline-block; width: 20px;">__</span> Negative<br/><span style="display: inline-block; width: 20px;">✓</span> Cannot be determined (indeterminate)</p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">__</span> Progesterone Receptor (PgR)</p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">✓</span> HER2 (by immunohistochemistry)</p><p style="margin-left: 40px;"><span style="display: inline-block; width: 20px;">✓</span> Negative (Score 0)<br/><span style="display: inline-block; width: 20px;">__</span> Negative (Score 1+)<br/><span style="display: inline-block; width: 20px;">__</span> Equivocal (Score 2+)<br/><span style="display: inline-block; width: 20px;">__</span> Positive (Score 3+)<br/><span style="display: inline-block; width: 20px;">__</span> Cannot be determined (indeterminate)</p><p style="margin-left: 20px;"><span style="display: inline-block; width: 20px;">__</span> HER2 (by in situ hybridization)</p></div>
          </text>
          <entry>🔗 
            <reference value="Observation/observation-section-specimen"/>
          </entry>
        </section>
      </Composition>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/DiagnosticReport/diagnosticreport-breast-invasive-carcinoma"/>
    <resource>
      <DiagnosticReport>
        <id value="diagnosticreport-breast-invasive-carcinoma"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-diagnostic-report"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="DiagnosticReport_diagnosticreport-breast-invasive-carcinoma"> </a><p class="res-header-id"><b>Generated Narrative: DiagnosticReport diagnosticreport-breast-invasive-carcinoma</b></p><a name="diagnosticreport-breast-invasive-carcinoma"> </a><a name="hcdiagnosticreport-breast-invasive-carcinoma"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-diagnostic-report.html">US Pathology Diagnostic Report</a></p></div><h2><span title="Codes:{http://loinc.org 60568-3}">Pathology Synoptic report</span> (<span title="Codes:{http://loinc.org LP7839-6}">Pathology</span>) </h2><table class="grid"><tr><td>Subject</td><td>Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</td></tr><tr><td>When For</td><td>2025-03-18 21:39:30+0000</td></tr><tr><td>Performer</td><td> <a href="PractitionerRole-practitionerrole-uspath-pathologist.html">PractitionerRole Primary Interpreter</a></td></tr><tr><td>Identifier</td><td> <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:7c9139fe-ddd5-49d9-b649-f37344e8b995</td></tr></table><p><b>Report Details</b></p><table class="grid"><tr><td><b>Code</b></td><td><b>Value</b></td><td><b>Flags</b></td><td><b>When For</b></td></tr><tr><td><a href="Observation-observation-section-specimen.html"><span title="Codes:{http://cap.org/eCC 16182.100004300}">SPECIMEN</span></a></td><td/><td>Final</td><td>2025-03-18</td></tr><tr><td><a href="Observation-observation-section-tumor.html"><span title="Codes:{http://cap.org/eCC 16249.100004300}">TUMOR</span></a></td><td/><td>Final</td><td>2024-12-05</td></tr><tr><td><a href="Observation-observation-section-tumor-extent.html"><span title="Codes:{http://cap.org/eCC 16403.100004300}">Tumor Extent (Note H)</span></a></td><td/><td>Final</td><td>2025-03-18 14:52:02+0000 --&gt; (ongoing)</td></tr><tr><td><a href="Observation-observation-section-lymph-nodes.html"><span title="Codes:{http://cap.org/eCC 868263.100004300}">Lymph Nodes</span></a></td><td/><td>Final</td><td>2025-03-18</td></tr><tr><td><a href="Observation-observation-section-margins.html"><span title="Codes:{http://cap.org/eCC 16567.100004300}">MARGINS (Note L)</span></a></td><td/><td>Final</td><td>2025-03-18</td></tr><tr><td><a href="Observation-observation-section-regional-lymph-nodes.html"><span title="Codes:{http://cap.org/eCC 16697.100004300}">REGIONAL LYMPH NODES (Note M)</span></a></td><td/><td>Final</td><td>2025-03-18</td></tr><tr><td><a href="Observation-observation-section-distant-metastasis.html"><span title="Codes:{http://cap.org/eCC 352333.100004300}">Distant Metastasis</span></a></td><td/><td>Final</td><td>2025-03-18</td></tr><tr><td><a href="Observation-observation-section-ptnm-classification.html"><span title="Codes:{http://cap.org/eCC 16717.100004300}">PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition) (Note M)</span></a></td><td/><td>Final</td><td>2025-03-18</td></tr><tr><td><a href="Observation-observation-section-additional-findings.html"><span title="Codes:{http://cap.org/eCC 16782.100004300}">ADDITIONAL FINDINGS (Note N)</span></a></td><td/><td>Final</td><td>2025-03-18</td></tr><tr><td><a href="Observation-observation-section-special-studies.html"><span title="Codes:{http://cap.org/eCC 17834.100004300}">SPECIAL STUDIES</span></a></td><td/><td>Final</td><td>2025-03-18</td></tr><tr><td><a href="Observation-observation-section-comments.html"><span title="Codes:{http://cap.org/eCC 381061.100004300}">COMMENTS</span></a></td><td/><td>Final</td><td>2025-03-18</td></tr></table></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:7c9139fe-ddd5-49d9-b649-f37344e8b995"/>
        </identifier>
        <basedOn>🔗 
          <reference value="ServiceRequest/servicerequest-cancer-path"/>
        </basedOn>
        <status value="final"/>
        <category>
          <coding>
            <system value="http://loinc.org"/>
            <code value="LP7839-6"/>
            <display value="Pathology"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://loinc.org"/>
            <code value="60568-3"/>
            <display value="Pathology Synoptic report"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
          <display value="Annie Oakley"/>
        </subject>
        <encounter>🔗 
          <reference value="Encounter/encounter-uspath-specimen-collection"/>
        </encounter>
        <effectiveDateTime value="2025-03-18T21:39:30.000Z"/>
        <performer>🔗 
          <reference
                     value="PractitionerRole/practitionerrole-uspath-pathologist"/>
        </performer>
        <resultsInterpreter>🔗 
          <reference
                     value="PractitionerRole/practitionerrole-uspath-pathologist"/>
        </resultsInterpreter>
        <specimen>🔗 
          <reference value="Specimen/specimen-breast"/>
        </specimen>
        <result>🔗 
          <reference value="Observation/observation-section-specimen"/>
        </result>
        <result>🔗 
          <reference value="Observation/observation-section-tumor"/>
        </result>
        <result>🔗 
          <reference value="Observation/observation-section-tumor-extent"/>
        </result>
        <result>🔗 
          <reference value="Observation/observation-section-lymph-nodes"/>
        </result>
        <result>🔗 
          <reference value="Observation/observation-section-margins"/>
        </result>
        <result>🔗 
          <reference
                     value="Observation/observation-section-regional-lymph-nodes"/>
        </result>
        <result>🔗 
          <reference
                     value="Observation/observation-section-distant-metastasis"/>
        </result>
        <result>🔗 
          <reference
                     value="Observation/observation-section-ptnm-classification"/>
        </result>
        <result>🔗 
          <reference
                     value="Observation/observation-section-additional-findings"/>
        </result>
        <result>🔗 
          <reference value="Observation/observation-section-special-studies"/>
        </result>
        <result>🔗 
          <reference value="Observation/observation-section-comments"/>
        </result>
        <presentedForm>
          <contentType value="application/xml"/>
          <data
                value="<SDCSubmissionPackage pkgInstanceURI="1234" pkgInstanceVersionURI="1234" pkgPreviousInstanceVersionURI="1234" pkgDateTimeStamp="2021-03-10T19:32:40" xmlns="urn:ihe:qrph:sdc:2016">
	<FormDesign xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" order="0" ID="Adrenal.Bx.Res.Demog_129_3.002.011.RC1_sdcFDF" baseURI="cap.org" fullURI="_baseURI=cap.org&amp;_lineage=Adrenal.Bx.Res.129&amp;_version=3.002.011.RC1&amp;_docType=sdcFDF" filename="Adrenal.Bx.Res.129_3.002.011.RC1_sdcFDF.xml" lineage="Adrenal.Bx.Res.129" formTitle="ADRENAL GLAND" version="3.002.011.RC1" formInstanceURI="c5061ad0-448f-41b3-94f4-7caf93cd00ae" formInstanceVersionURI="c5061ad0-448f-41b3-94f4-7caf93cd00ae/ver1">
		<Property name="Copyright" type="CAPeCC_static_text" styleClass="copyright" order="1" propName="Copyright" val="(c) 2018 College of American Pathologists.  All rights reserved.  License required for use." />
		<Property name="GenericHeaderText" type="CAPeCC_static_text" order="2" propName="GenericHeaderText" val="Surgical Pathology Cancer Case Summary (Checklist)" />
		<Property name="Category" type="CAPeCC_meta" order="3" propName="Category" val="Endocrine" />
		<Property name="OfficialName" type="CAPeCC_meta" order="4" propName="OfficialName" val="ADRENAL GLAND" />
		<Property name="CAP_ProtocolName" type="CAPeCC_meta" order="5" propName="CAP_ProtocolName" val="Adrenal Gland" />
		<Property name="CAP_ProtocolVersion" type="CAPeCC_meta" order="6" propName="CAP_ProtocolVersion" val="4.0.1.1" />
		<Property name="TemplateID" type="CAPeCC_meta" order="7" propName="TemplateID" val="129.100004300" />
		<Property name="Restrictions" type="CAPeCC_meta" order="8" propName="Restrictions" val="Please refer to the cancer protocol cover page (www.cap.org/cancerprotocols) for information about which tumor types and procedures can be reported using this template." />
		<Property name="CAP_Required" type="CAPeCC_meta" order="9" propName="CAP_Required" val="true" />
		<Property name="AccreditationDate" type="CAPeCC_meta dt.dateTime" order="10" propName="AccreditationDate" val="2/28/2018 12:00:00 AM" />
		<Property name="WebPostingDate" type="CAPeCC_meta dt.dateTime" order="11" propName="WebPostingDate" val="6/30/2017 12:00:00 AM" />
		<Property name="ShortName" type="CAPeCC_meta" order="12" propName="ShortName" val="Adrenal.Bx.Res" />
		<Property name="ApprovalStatus" type="CAPeCC_meta" order="13" propName="ApprovalStatus" val="RC1" />
		<Property name="AJCC_Version" type="CAPeCC_meta" order="14" propName="AJCC_Version" val="8th Edition" />
		<Body name="Body" order="15" ID="Adrenal.Bx.Res.129_3.002.011.RC1_sdcFDF_Body">
			<ChildItems name="ch_Body" order="16">
				<DisplayedItem name="DI_39617" order="17" ID="39617.100004300" title="# This checklist applies principally to adrenal carcinomas in adults. Pediatric adrenal cortical tumors have different criteria for malignancy and are, in general, treated under protocols that may differ significantly from the recommendations for adult- type tumors.">
					<Property name="p_rptTxt_39617_1" order="18" propName="reportText" val="{no text}" />
				</DisplayedItem>
				<Section name="S_4257" order="19" ID="4257.100004300" minCard="0">
					<ChildItems name="ch_4257_1" order="20">
						<Question name="Q_Tum_Site_2118" order="21" ID="2118.100004300" minCard="0" readOnly="true">
							<Property name="p_rptTxt_2118_1" order="22" propName="reportText" val="{no text}" />
							<ListField name="lf_2118_2" order="23">
								<List name="lst_2118_3" order="24">
									<ListItem name="LI_Adrenal_Gland_2119" order="25" ID="2119.100004300" title="Adrenal gland" selected="true">
										<Property name="p_rptTxt_2119_1" order="26" propName="reportText" val="{no text}" />
									</ListItem>
								</List>
							</ListField>
						</Question>
					</ChildItems>
				</Section>
				<Section name="S_17537" order="27" ID="17537.100004300" title="CLINICAL" mustImplement="false" minCard="0">
					<ChildItems name="ch_17537_1" order="28">
						<Question name="Q_Oth_Non_Path_Findings_4156" order="29" ID="4156.100004300" title="Clinical History (specify)" mustImplement="false" minCard="0">
							<Property name="p_rptTxt_4156_1" order="30" propName="reportText" val="Clinical History" />
							<ResponseField name="rf_4156_2" order="31">
								<Response name="rsp_4156_3" order="32">
									<string name="str_4156_4" order="33" maxLength="4000" />
								</Response>
							</ResponseField>
						</Question>
						<Question name="Q_53772" order="34" ID="53772.100004300" title="Functional Status (Notes J and K)" mustImplement="false" minCard="0">
							<Property name="p_rptTxt_53772_1" order="35" propName="reportText" val="Functional Status" />
							<ListField name="lf_53772_2" order="36" maxSelections="0">
								<List name="lst_53772_3" order="37">
									<ListItem name="LI_Urin_17-ketosteroids_increased_20900" order="38" ID="20900.100004300" title="Urinary 17-ketosteroids increased (10 mg / g creatinine / 24 hours)" />
									<ListItem name="LI_Cushing_Synd_20902" order="39" ID="20902.100004300" title="Cushing syndrome" />
									<ListItem name="LI_Conn_Synd_20904" order="40" ID="20904.100004300" title="Conn syndrome" />
									<ListItem name="LI_43052" order="41" ID="43052.100004300" title="Virilization" />
									<ListItem name="LI_44618" order="42" ID="44618.100004300" title="Feminization" />
									<ListItem name="LI_Weight_Loss_20906" order="43" ID="20906.100004300" title="Weight loss" />
									<ListItem name="LI_Oth_20907" order="44" ID="20907.100004300" title="Other (specify)">
										<Property name="p_rptTxt_20907_1" order="45" propName="reportText" val="{no text}" />
										<ListItemResponseField name="lirf_20907_2" order="46" responseRequired="true">
											<Response name="rsp_20907_3" order="47">
												<string name="str_20907_4" order="48" maxLength="4000" />
											</Response>
										</ListItemResponseField>
									</ListItem>
								</List>
							</ListField>
						</Question>
					</ChildItems>
				</Section>
				<Section name="S_17875" order="49" ID="17875.100004300" title="SPECIMEN">
					<ChildItems name="ch_17875_1" order="50">
						<Question name="Q_Procedure_42554" order="51" ID="42554.100004300" title="Procedure">
							<ListField name="lf_42554_1" order="52">
								<List name="lst_42554_2" order="53">
									<ListItem name="LI_50809" order="54" ID="50809.100004300" title="Percutaneous needle biopsy" />
									<ListItem name="LI_46633" order="55" ID="46633.100004300" title="Endoscopic directed biopsy (specify radiographic technique)">
										<Property name="p_rptTxt_46633_1" order="56" propName="reportText" val="Endoscopic directed biopsy" />
										<ListItemResponseField name="lirf_46633_2" order="57" responseRequired="true">
											<Response name="rsp_46633_3" order="58">
												<string name="str_46633_4" order="59" maxLength="4000" />
											</Response>
										</ListItemResponseField>
									</ListItem>
									<ListItem name="LI_Adrenalectomy_Total_2122" order="60" ID="2122.100004300" title="Adrenalectomy, total" selected="true" />
									<ListItem name="LI_Adrenalectomy_Part_2121" order="61" ID="2121.100004300" title="Adrenalectomy, partial" />
									<ListItem name="LI_Oth_2123" order="62" ID="2123.100004300" title="Other (specify)">
										<Property name="p_rptTxt_2123_1" order="63" propName="reportText" val="{no text}" />
										<ListItemResponseField name="lirf_2123_2" order="64" responseRequired="true">
											<Response name="rsp_2123_3" order="65">
												<string name="str_2123_4" order="66" maxLength="4000" />
											</Response>
										</ListItemResponseField>
									</ListItem>
									<ListItem name="LI_NS_2124" order="67" ID="2124.100004300" title="Not specified" />
								</List>
							</ListField>
						</Question>
						<Question name="Q_52756" order="68" ID="52756.100004300" title="Specimen Laterality">
							<ListField name="lf_52756_1" order="69">
								<List name="lst_52756_2" order="70">
									<ListItem name="LI_Right_2126" order="71" ID="2126.100004300" title="Right" />
									<ListItem name="LI_Left_2127" order="72" ID="2127.100004300" title="Left" selected="true" />
									<ListItem name="LI_56812" order="73" ID="56812.100004300" title="Bilateral" />
									<ListItem name="LI_NS_2128" order="74" ID="2128.100004300" title="Not specified" />
									<ListItem name="LI_Oth_20866" order="75" ID="20866.100004300" title="Other (specify)">
										<Property name="p_rptTxt_20866_1" order="76" propName="reportText" val="{no text}" />
										<ListItemResponseField name="lirf_20866_2" order="77" responseRequired="true">
											<Response name="rsp_20866_3" order="78">
												<string name="str_20866_4" order="79" maxLength="4000" />
											</Response>
										</ListItemResponseField>
									</ListItem>
								</List>
							</ListField>
						</Question>
					</ChildItems>
				</Section>
				<Section name="S_17876" order="80" ID="17876.100004300" title="TUMOR">
					<ChildItems name="ch_17876_1" order="81">
						<Question name="Q_59852" order="82" ID="59852.100004300" title="Histologic Type (Notes C through E)">
							<Property name="p_rptTxt_59852_1" order="83" propName="reportText" val="Histologic Type" />
							<ListField name="lf_59852_2" order="84">
								<List name="lst_59852_3" order="85">
									<ListItem name="LI_46925" order="86" ID="46925.100004300" title="Adrenal cortical carcinoma, oncocytic type" />
									<ListItem name="LI_Adrenal_Cortical_Ca_2117" order="87" ID="2117.100004300" title="Adrenal cortical carcinoma" selected="true" />
									<ListItem name="LI_44449" order="88" ID="44449.100004300" title="Adrenal cortical carcinoma, myxoid type" />
									<ListItem name="LI_59162" order="89" ID="59162.100004300" title="Adrenal cortical carcinoma, sarcomatoid type" />
								</List>
							</ListField>
							<ChildItems name="ch_59852_1" order="90">
								<Question name="Q_43670" order="91" ID="43670.100004300" title="Histologic Type Comments" mustImplement="false" minCard="0">
									<ResponseField name="rf_43670_1" order="92">
										<Response name="rsp_43670_2" order="93">
											<string name="str_43670_3" order="94" maxLength="4000" />
										</Response>
									</ResponseField>
								</Question>
							</ChildItems>
						</Question>
						<Question name="Q_49275" order="95" ID="49275.100004300" title="Histologic Grade (Notes C through E)">
							<Property name="p_rptTxt_49275_1" order="96" propName="reportText" val="Histologic Grade" />
							<ListField name="lf_49275_2" order="97">
								<List name="lst_49275_3" order="98">
									<ListItem name="LI_53603" order="99" ID="53603.100004300" title="Low grade (&lt;= 20 mitoses / 50 high-power fields)" selected="true">
										<Property name="p_rptTxt_53603_1" order="100" propName="reportText" val="Low grade" />
									</ListItem>
									<ListItem name="LI_48634" order="101" ID="48634.100004300" title="High grade (&gt; 20 mitoses / 50 high-power fields)">
										<Property name="p_rptTxt_48634_1" order="102" propName="reportText" val="High grade" />
									</ListItem>
									<DisplayedItem name="DI_57980" order="103" ID="57980.100004300" title="#Note: Generally due to core needle biopsy, with insufficient viable tumor to count 50 HPFs.">
										<Property name="p_rptTxt_57980_1" order="104" propName="reportText" val="{no text}" />
									</DisplayedItem>
									<ListItem name="LI_54648" order="105" ID="54648.100004300" title="Cannot be assessed (explain)#">
										<Property name="p_rptTxt_54648_1" order="106" propName="reportText" val="Cannot be assessed" />
										<ListItemResponseField name="lirf_54648_2" order="107" responseRequired="true">
											<Response name="rsp_54648_3" order="108">
												<string name="str_54648_4" order="109" maxLength="4000" />
											</Response>
										</ListItemResponseField>
									</ListItem>
								</List>
							</ListField>
						</Question>
						<Question name="Q_Tum_Size_2129" order="110" ID="2129.100004300" title="Tumor Size (Note A)">
							<Property name="p_rptTxt_2129_1" order="111" propName="reportText" val="Tumor Size" />
							<ListField name="lf_2129_2" order="112">
								<List name="lst_2129_3" order="113">
									<ListItem name="LI_TSize1_2131" order="114" ID="2131.100004300" title="Greatest dimension in Centimeters (cm)" selected="true">
										<ListItemResponseField name="lirf_2131_1" order="115" responseRequired="true">
											<Response name="rsp_2131_2" order="116">
												<decimal name="dec_2131_3" order="117" minInclusive="0.001000000" maxInclusive="100.000000000" fractionDigits="3" totalDigits="5" val="3" />
											</Response>
											<TextAfterResponse name="rtt_2131_4" order="118" val="Centimeters (cm)" />
											<ResponseUnits name="un_2131_5" order="119" val="cm" unitSystem="UCOM" />
										</ListItemResponseField>
										<ChildItems name="ch_2131_6" order="120">
											<Question name="Q_Tum_Add_Dim_2133" order="121" ID="2133.100004300" title="Additional Dimension in Centimeters (cm)" mustImplement="false" minCard="0">
												<ResponseField name="rf_2133_1" order="122">
													<Response name="rsp_2133_2" order="123">
														<decimal name="dec_2133_3" order="124" minInclusive="0.001000000" maxInclusive="100.000000000" fractionDigits="3" totalDigits="5" val="3" />
													</Response>
													<TextAfterResponse name="rtt_2133_4" order="125" val="Centimeters (cm)" />
													<ResponseUnits name="un_2133_5" order="126" val="cm" unitSystem="UCOM" />
												</ResponseField>
											</Question>
											<Question name="Q_Tum_Add_Dim_2132" order="127" ID="2132.100004300" title="Additional Dimension in Centimeters (cm)" mustImplement="false" minCard="0">
												<ResponseField name="rf_2132_1" order="128">
													<Response name="rsp_2132_2" order="129">
														<decimal name="dec_2132_3" order="130" minInclusive="0.001000000" maxInclusive="100.000000000" fractionDigits="3" totalDigits="5" val="3" />
													</Response>
													<TextAfterResponse name="rtt_2132_4" order="131" val="Centimeters (cm)" />
													<ResponseUnits name="un_2132_5" order="132" val="cm" unitSystem="UCOM" />
												</ResponseField>
											</Question>
										</ChildItems>
									</ListItem>
									<ListItem name="LI_CBD_2130" order="133" ID="2130.100004300" title="Cannot be determined (explain)">
										<Property name="p_rptTxt_2130_1" order="134" propName="reportText" val="Cannot be determined" />
										<ListItemResponseField name="lirf_2130_2" order="135" responseRequired="true">
											<Response name="rsp_2130_3" order="136">
												<string name="str_2130_4" order="137" maxLength="4000" />
											</Response>
										</ListItemResponseField>
									</ListItem>
								</List>
							</ListField>
						</Question>
						<Question name="Q_Tum_Gland_Weight_40496" order="138" ID="40496.100004300" title="Tumor Weight (Note B)">
							<Property name="p_rptTxt_40496_1" order="139" propName="reportText" val="Tumor Weight" />
							<ListField name="lf_40496_2" order="140">
								<List name="lst_40496_3" order="141">
									<ListItem name="LI_Tum_Gland_Weight_g_44761" order="142" ID="44761.100004300" title="Specify weight (g)">
										<Property name="p_rptTxt_44761_1" order="143" propName="reportText" val="{no text}" />
										<ListItemResponseField name="lirf_44761_2" order="144" responseRequired="true">
											<Response name="rsp_44761_3" order="145">
												<decimal name="dec_44761_4" order="146" minInclusive="0.000000000" maxInclusive="50000.000000000" fractionDigits="2" totalDigits="7" />
											</Response>
											<TextAfterResponse name="rtt_44761_5" order="147" val="g" />
											<ResponseUnits name="un_44761_6" order="148" val="grams" unitSystem="UCOM" />
										</ListItemResponseField>
									</ListItem>
									<ListItem name="LI_NA_57476" order="149" ID="57476.100004300" title="Cannot be determined" selected="true">
										<ListItemResponseField name="lirf_57476_1" order="150">
											<Response name="rsp_57476_2" order="151">
												<string name="str_57476_3" order="152" maxLength="4000" />
											</Response>
										</ListItemResponseField>
									</ListItem>
								</List>
							</ListField>
						</Question>
						<Section name="S_17877" order="153" ID="17877.100004300" title="Tumor Extent">
							<Property name="p_rptTxt_17877_1" order="154" propName="reportText" val="{no text}" />
							<ChildItems name="ch_17877_2" order="155">
								<Question name="Q_51265" order="156" ID="51265.100004300" title="Tumor Extension">
									<ListField name="lf_51265_1" order="157" maxSelections="0">
										<List name="lst_51265_2" order="158">
											<ListItem name="LI_44186" order="159" ID="44186.100004300" title="No evidence of primary tumor" selectionDeselectsSiblings="true" />
											<ListItem name="LI_50695" order="160" ID="50695.100004300" title="Tumor confined to adrenal cortex without invasion through tumor capsule (if present)" selectionDeselectsSiblings="true">
												<Property name="p_rptTxt_50695_1" order="161" propName="reportText" val="Tumor confined to adrenal cortex without invasion through tumor capsule" />
											</ListItem>
											<ListItem name="LI_39537" order="162" ID="39537.100004300" title="Tumor invades into or through the adrenal capsule" />
											<ListItem name="LI_52315" order="163" ID="52315.100004300" title="Tumor invades into extra-adrenal structures (specify)">
												<Property name="p_rptTxt_52315_1" order="164" propName="reportText" val="Tumor invades into extra-adrenal structures" />
												<ListItemResponseField name="lirf_52315_2" order="165" responseRequired="true">
													<Response name="rsp_52315_3" order="166">
														<string name="str_52315_4" order="167" maxLength="4000" />
													</Response>
												</ListItemResponseField>
											</ListItem>
											<ListItem name="LI_56271" order="168" ID="56271.100004300" title="Tumor invades into other adjacent organ(s)" selected="true">
												<ChildItems name="ch_56271_1" order="169">
													<Question name="Q_53526" order="170" ID="53526.100004300">
														<ListField name="lf_53526_1" order="171" maxSelections="0">
															<List name="lst_53526_2" order="172">
																<ListItem name="LI_56752" order="173" ID="56752.100004300" title="Kidney" />
																<ListItem name="LI_57748" order="174" ID="57748.100004300" title="Pancreas" selected="true" />
																<ListItem name="LI_41409" order="175" ID="41409.100004300" title="Liver" />
																<ListItem name="LI_42305" order="176" ID="42305.100004300" title="Spleen" />
																<ListItem name="LI_58229" order="177" ID="58229.100004300" title="Diaphragm" />
																<ListItem name="LI_46218" order="178" ID="46218.100004300" title="Stomach" />
																<ListItem name="LI_45594" order="179" ID="45594.100004300" title="Other (specify)">
																	<Property name="p_rptTxt_45594_1" order="180" propName="reportText" val="{no text}" />
																	<ListItemResponseField name="lirf_45594_2" order="181" responseRequired="true">
																		<Response name="rsp_45594_3" order="182">
																			<string name="str_45594_4" order="183" maxLength="4000" />
																		</Response>
																	</ListItemResponseField>
																</ListItem>
															</List>
														</ListField>
													</Question>
												</ChildItems>
											</ListItem>
											<ListItem name="LI_Indeterminate_51911" order="184" ID="51911.100004300" title="Cannot be assessed" selectionDeselectsSiblings="true">
												<ListItemResponseField name="lirf_51911_1" order="185">
													<Response name="rsp_51911_2" order="186">
														<string name="str_51911_3" order="187" maxLength="4000" />
													</Response>
												</ListItemResponseField>
											</ListItem>
										</List>
									</ListField>
								</Question>
							</ChildItems>
						</Section>
						<Section name="S_17879" order="188" ID="17879.100004300" title="Accessory Findings">
							<ChildItems name="ch_17879_1" order="189">
								<Question name="Q_42474" order="190" ID="42474.100004300" title="Lymphovascular Invasion (Note F)">
									<Property name="p_rptTxt_42474_1" order="191" propName="reportText" val="Lymphovascular Invasion" />
									<ListField name="lf_42474_2" order="192" maxSelections="0">
										<List name="lst_42474_3" order="193">
											<ListItem name="LI_Not_Id_2159" order="194" ID="2159.100004300" title="Not identified" selectionDeselectsSiblings="true" />
											<ListItem name="LI_52962" order="195" ID="52962.100004300" title="Large vessel, renal vein (including when identified clinically)" selected="true">
												<Property name="p_rptTxt_52962_1" order="196" propName="reportText" val="Large vessel, renal vein" />
											</ListItem>
											<ListItem name="LI_59454" order="197" ID="59454.100004300" title="Large vessel, vena cava (including when identified clinically)">
												<Property name="p_rptTxt_59454_1" order="198" propName="reportText" val="Large vessel, vena cava" />
											</ListItem>
											<ListItem name="LI_Sm_Vessel_20881" order="199" ID="20881.100004300" title="Small vessel (capillary lymphatic)" selected="true" />
											<ListItem name="LI_Indeterminate_2161" order="200" ID="2161.100004300" title="Cannot be determined" selectionDeselectsSiblings="true">
												<ListItemResponseField name="lirf_2161_1" order="201">
													<Response name="rsp_2161_2" order="202">
														<string name="str_2161_3" order="203" maxLength="4000" />
													</Response>
												</ListItemResponseField>
											</ListItem>
										</List>
									</ListField>
								</Question>
								<Question name="Q_48491" order="204" ID="48491.100004300" title="Tumor Description" mustImplement="false" minCard="0">
									<ListField name="lf_48491_1" order="205" maxSelections="0">
										<List name="lst_48491_2" order="206">
											<ListItem name="LI_Hemorrhagic_20863" order="207" ID="20863.100004300" title="Hemorrhagic" />
											<ListItem name="LI_Necrotic_20864" order="208" ID="20864.100004300" title="Necrotic" />
											<ListItem name="LI_Oth_20865" order="209" ID="20865.100004300" title="Other (specify)">
												<Property name="p_rptTxt_20865_1" order="210" propName="reportText" val="{no text}" />
												<ListItemResponseField name="lirf_20865_2" order="211" responseRequired="true">
													<Response name="rsp_20865_3" order="212">
														<string name="str_20865_4" order="213" maxLength="4000" />
													</Response>
												</ListItemResponseField>
											</ListItem>
										</List>
									</ListField>
								</Question>
							</ChildItems>
						</Section>
					</ChildItems>
				</Section>
				<Section name="S_17878" order="214" ID="17878.100004300" title="MARGINS">
					<ChildItems name="ch_17878_1" order="215">
						<Question name="Q_Marg_Status_2153" order="216" ID="2153.100004300" title="Margins">
							<ListField name="lf_2153_1" order="217">
								<List name="lst_2153_2" order="218">
									<ListItem name="LI_MargUnv_Tum_2154" order="219" ID="2154.100004300" title="Uninvolved by tumor" selected="true">
										<ChildItems name="ch_2154_1" order="220">
											<Question name="Q_MargUnv_Tum_Dist_26358" order="221" ID="26358.100004300" title="Distance from Closest Margin in Millimeters (mm)" mustImplement="false" minCard="0">
												<ListField name="lf_26358_1" order="222">
													<List name="lst_26358_2" order="223">
														<ListItem name="LI_Spfy_mm_26359" order="224" ID="26359.100004300" title="Specify in Millimeters (mm)">
															<Property name="p_rptTxt_26359_1" order="225" propName="reportText" val="{no text}" />
															<ListItemResponseField name="lirf_26359_2" order="226" responseRequired="true">
																<Response name="rsp_26359_3" order="227">
																	<decimal name="dec_26359_4" order="228" minInclusive="0.010000000" maxInclusive="1000.000000000" fractionDigits="2" totalDigits="5" />
																</Response>
																<TextAfterResponse name="rtt_26359_5" order="229" val="Millimeters (mm)" />
																<ResponseUnits name="un_26359_6" order="230" val="mm" unitSystem="UCOM" />
															</ListItemResponseField>
														</ListItem>
														<ListItem name="LI_CBA_26361" order="231" ID="26361.100004300" title="Cannot be determined (explain)">
															<Property name="p_rptTxt_26361_1" order="232" propName="reportText" val="Cannot be determined" />
															<ListItemResponseField name="lirf_26361_2" order="233" responseRequired="true">
																<Response name="rsp_26361_3" order="234">
																	<string name="str_26361_4" order="235" maxLength="4000" />
																</Response>
															</ListItemResponseField>
														</ListItem>
													</List>
												</ListField>
											</Question>
											<Question name="Q_Marg_Loc_26362" order="236" ID="26362.100004300" title="?Specify Margin, if possible">
												<Property name="p_rptTxt_26362_1" order="237" propName="reportText" val="Margin" />
												<ListField name="lf_26362_2" order="238">
													<List name="lst_26362_3" order="239">
														<ListItem name="LI_Marg_Loc_26363" order="240" ID="26363.100004300" title="Specify margin">
															<Property name="p_rptTxt_26363_1" order="241" propName="reportText" val="{no text}" />
															<ListItemResponseField name="lirf_26363_2" order="242" responseRequired="true">
																<Response name="rsp_26363_3" order="243">
																	<string name="str_26363_4" order="244" maxLength="4000" />
																</Response>
															</ListItemResponseField>
														</ListItem>
														<ListItem name="LI_CBD_26364" order="245" ID="26364.100004300" title="?Cannot be determined" omitWhenSelected="true" selected="true">
															<Property name="p_rptTxt_26364_1" order="246" propName="reportText" val="Cannot be determined" />
															<ListItemResponseField name="lirf_26364_2" order="247">
																<Response name="rsp_26364_3" order="248">
																	<string name="str_26364_4" order="249" maxLength="4000" />
																</Response>
															</ListItemResponseField>
														</ListItem>
													</List>
												</ListField>
											</Question>
										</ChildItems>
									</ListItem>
									<ListItem name="LI_Marg_Tum_2155" order="250" ID="2155.100004300" title="Involved by tumor">
										<ChildItems name="ch_2155_1" order="251">
											<Question name="Q_Marg_Loc_26365" order="252" ID="26365.100004300" title="?Specify Margin(s), if possible">
												<Property name="p_rptTxt_26365_1" order="253" propName="reportText" val="Margin(s)" />
												<ListField name="lf_26365_2" order="254">
													<List name="lst_26365_3" order="255">
														<ListItem name="LI_Marg_Loc_26366" order="256" ID="26366.100004300" title="Specify margin(s)">
															<Property name="p_rptTxt_26366_1" order="257" propName="reportText" val="{no text}" />
															<ListItemResponseField name="lirf_26366_2" order="258" responseRequired="true">
																<Response name="rsp_26366_3" order="259">
																	<string name="str_26366_4" order="260" maxLength="4000" />
																</Response>
															</ListItemResponseField>
														</ListItem>
														<ListItem name="LI_CBD_26367" order="261" ID="26367.100004300" title="?Cannot be determined" omitWhenSelected="true">
															<Property name="p_rptTxt_26367_1" order="262" propName="reportText" val="Cannot be determined" />
															<ListItemResponseField name="lirf_26367_2" order="263">
																<Response name="rsp_26367_3" order="264">
																	<string name="str_26367_4" order="265" maxLength="4000" />
																</Response>
															</ListItemResponseField>
														</ListItem>
													</List>
												</ListField>
											</Question>
										</ChildItems>
									</ListItem>
									<ListItem name="LI_CBD_2157" order="266" ID="2157.100004300" title="Cannot be assessed">
										<ListItemResponseField name="lirf_2157_1" order="267">
											<Response name="rsp_2157_2" order="268">
												<string name="str_2157_3" order="269" maxLength="4000" />
											</Response>
										</ListItemResponseField>
									</ListItem>
									<ListItem name="LI_NA_20852" order="270" ID="20852.100004300" title="Not applicable">
										<ListItemResponseField name="lirf_20852_1" order="271">
											<Response name="rsp_20852_2" order="272">
												<string name="str_20852_3" order="273" maxLength="4000" />
											</Response>
										</ListItemResponseField>
									</ListItem>
								</List>
							</ListField>
						</Question>
					</ChildItems>
				</Section>
				<Section name="S_17881" order="274" ID="17881.100004300" title="LYMPH NODES">
					<ChildItems name="ch_17881_1" order="275">
						<Question name="Q_1867" order="276" ID="1867.100004300" title="Regional Lymph Nodes">
							<ListField name="lf_1867_1" order="277" maxSelections="0">
								<List name="lst_1867_2" order="278">
									<ListItem name="LI_No_LN_Id_1868" order="279" ID="1868.100004300" title="No lymph nodes submitted or found" selectionDisablesChildren="true">
										<ChildItems name="ch_1868_1" order="280">
											<Question name="Q_45098" order="281" ID="45098.100004300" title="Number of Lymph Nodes Involved">
												<ListField name="lf_45098_1" order="282">
													<List name="lst_45098_2" order="283">
														<ListItem name="LI_Specify_1873" order="284" ID="1873.100004300" title="Specify number">
															<Property name="p_rptTxt_1873_1" order="285" propName="reportText" val="{no text}" />
															<ListItemResponseField name="lirf_1873_2" order="286" responseRequired="true">
																<Response name="rsp_1873_3" order="287">
																	<integer name="intr_1873_4" order="288" maxInclusive="100" minInclusive="0" />
																</Response>
															</ListItemResponseField>
														</ListItem>
														<ListItem name="LI_58938" order="289" ID="58938.100004300" title="At least">
															<ListItemResponseField name="lirf_58938_1" order="290" responseRequired="true">
																<Response name="rsp_58938_2" order="291">
																	<integer name="intr_58938_3" order="292" maxInclusive="100" minInclusive="1" />
																</Response>
															</ListItemResponseField>
														</ListItem>
														<ListItem name="LI_CBD_1874" order="293" ID="1874.100004300" title="Number cannot be determined (explain)" selected="true">
															<Property name="p_rptTxt_1874_1" order="294" propName="reportText" val="Number cannot be determined" />
															<ListItemResponseField name="lirf_1874_2" order="295" responseRequired="true">
																<Response name="rsp_1874_3" order="296">
																	<string name="str_1874_4" order="297" maxLength="4000" />
																</Response>
															</ListItemResponseField>
														</ListItem>
													</List>
												</ListField>
												<ChildItems name="ch_45098_5" order="298">
													<Question name="Q_39296" order="299" ID="39296.100004300" title="Extranodal Extension" mustImplement="false" minCard="0">
														<ListField name="lf_39296_1" order="300">
															<List name="lst_39296_2" order="301">
																<ListItem name="LI_Not_Id_20886" order="302" ID="20886.100004300" title="Not identified" />
																<ListItem name="LI_Present_20887" order="303" ID="20887.100004300" title="Present" />
																<ListItem name="LI_Indeterminate_20888" order="304" ID="20888.100004300" title="Cannot be determined">
																	<ListItemResponseField name="lirf_20888_1" order="305">
																		<Response name="rsp_20888_2" order="306">
																			<string name="str_20888_3" order="307" maxLength="4000" />
																		</Response>
																	</ListItemResponseField>
																</ListItem>
															</List>
														</ListField>
													</Question>
												</ChildItems>
											</Question>
											<Question name="Q_42934" order="308" ID="42934.100004300" title="Number of Lymph Nodes Examined">
												<ListField name="lf_42934_1" order="309">
													<List name="lst_42934_2" order="310">
														<ListItem name="LI_Specify_1870" order="311" ID="1870.100004300" title="Specify number">
															<Property name="p_rptTxt_1870_1" order="312" propName="reportText" val="{no text}" />
															<ListItemResponseField name="lirf_1870_2" order="313" responseRequired="true">
																<Response name="rsp_1870_3" order="314">
																	<integer name="intr_1870_4" order="315" maxInclusive="100" minInclusive="1" />
																</Response>
															</ListItemResponseField>
														</ListItem>
														<ListItem name="LI_54610" order="316" ID="54610.100004300" title="At least">
															<ListItemResponseField name="lirf_54610_1" order="317" responseRequired="true">
																<Response name="rsp_54610_2" order="318">
																	<integer name="intr_54610_3" order="319" maxInclusive="100" minInclusive="1" />
																</Response>
															</ListItemResponseField>
														</ListItem>
														<ListItem name="LI_CBD_1871" order="320" ID="1871.100004300" title="Number cannot be determined (explain)">
															<Property name="p_rptTxt_1871_1" order="321" propName="reportText" val="Number cannot be determined" />
															<ListItemResponseField name="lirf_1871_2" order="322" responseRequired="true">
																<Response name="rsp_1871_3" order="323">
																	<string name="str_1871_4" order="324" maxLength="4000" />
																</Response>
															</ListItemResponseField>
														</ListItem>
													</List>
												</ListField>
											</Question>
										</ChildItems>
									</ListItem>
								</List>
							</ListField>
						</Question>
					</ChildItems>
				</Section>
				<Section name="S_2136" order="325" ID="2136.100004300" title="PATHOLOGIC STAGE CLASSIFICATION  (pTNM, AJCC 8th Edition) (Note G)">
					<Property name="p_rptTxt_2136_1" order="326" propName="reportText" val="PATHOLOGIC STAGE CLASSIFICATION  (pTNM, AJCC 8th Edition)" />
					<ChildItems name="ch_2136_2" order="327">
						<DisplayedItem name="DI_51087" order="328" ID="51087.100004300" title="Note: Reporting of pT, pN, and (when applicable) pM categories is based on information available to the pathologist at the time the report is issued.  As per the AJCC (Chapter 1, 8th Ed.) it is the managing physicians responsibility to establish the final pathologic stage based upon all pertinent information, including but potentially not limited to this pathology report.">
							<Property name="p_rptTxt_51087_1" order="329" propName="reportText" val="Note: Reporting of pT, pN, and (when applicable) pM categories is based on information available to the pathologist at the time the report is issued.  As per the AJCC (Chapter 1, 8th Ed.) it is the managing physicians responsibility to establish the final pathologic stage based upon all pertinent information, including but potentially not limited to this pathology report." />
						</DisplayedItem>
						<Question name="Q_TNM_Descriptors_20880" order="330" ID="20880.100004300" title="?TNM Descriptors">
							<Property name="p_rptTxt_20880_1" order="331" propName="reportText" val="TNM Descriptors" />
							<ListField name="lf_20880_2" order="332" maxSelections="0">
								<List name="lst_20880_3" order="333">
									<ListItem name="LI_NA_22897" order="334" ID="22897.100004300" title="?Not applicable" selectionDeselectsSiblings="true" omitWhenSelected="true">
										<Property name="p_rptTxt_22897_1" order="335" propName="reportText" val="Not applicable" />
										<ListItemResponseField name="lirf_22897_2" order="336">
											<Response name="rsp_22897_3" order="337">
												<string name="str_22897_4" order="338" maxLength="4000" />
											</Response>
										</ListItemResponseField>
									</ListItem>
									<ListItem name="LI_m_20890" order="339" ID="20890.100004300" title="m (multiple primary tumors)" selected="true" />
									<ListItem name="LI_r_20891" order="340" ID="20891.100004300" title="r (recurrent)" />
									<ListItem name="LI_y_20892" order="341" ID="20892.100004300" title="y (post-treatment)" />
								</List>
							</ListField>
						</Question>
						<Question name="Q_pT_2137" order="342" ID="2137.100004300" title="Primary Tumor (pT)">
							<ListField name="lf_2137_1" order="343">
								<List name="lst_2137_2" order="344">
									<DisplayedItem name="DI_20894" order="345" ID="20894.100004300" title="Note: There is no category of carcinoma in situ (pTis) relative to carcinomas of the adrenal gland.">
										<Property name="p_rptTxt_20894_1" order="346" propName="reportText" val="{no text}" />
									</DisplayedItem>
									<ListItem name="LI_pTX_2142" order="347" ID="2142.100004300" title="pTX: Primary tumor cannot be assessed">
										<Property name="p_rptTxt_2142_1" order="348" propName="reportText" val="pTX" />
									</ListItem>
									<ListItem name="LI_pT0_20889" order="349" ID="20889.100004300" title="pT0: No evidence of primary tumor" selected="true">
										<Property name="p_rptTxt_20889_1" order="350" propName="reportText" val="pT0" />
									</ListItem>
									<ListItem name="LI_pT1_2138" order="351" ID="2138.100004300" title="pT1: Tumor &lt;= 5 cm in greatest dimension, no extra-adrenal invasion">
										<Property name="p_rptTxt_2138_1" order="352" propName="reportText" val="pT1" />
									</ListItem>
									<ListItem name="LI_pT2_2139" order="353" ID="2139.100004300" title="pT2: Tumor &gt; 5 cm, no extra-adrenal invasion">
										<Property name="p_rptTxt_2139_1" order="354" propName="reportText" val="pT2" />
									</ListItem>
									<ListItem name="LI_pT3_2140" order="355" ID="2140.100004300" title="pT3: Tumor of any size with local invasion, but not invading adjacent organs">
										<Property name="p_rptTxt_2140_1" order="356" propName="reportText" val="pT3" />
									</ListItem>
									<ListItem name="LI_pT4_2141" order="357" ID="2141.100004300" title="pT4: Tumor of any size with invasion of adjacent organs (kidney, diaphragm, pancreas, spleen, or liver) or large blood vessels (renal vein or vena cava)">
										<Property name="p_rptTxt_2141_1" order="358" propName="reportText" val="pT4" />
									</ListItem>
								</List>
							</ListField>
						</Question>
						<Question name="Q_pN_2143" order="359" ID="2143.100004300" title="Regional Lymph Nodes (pN) (Note H)">
							<Property name="p_rptTxt_2143_1" order="360" propName="reportText" val="Regional Lymph Nodes (pN)" />
							<ListField name="lf_2143_2" order="361">
								<List name="lst_2143_3" order="362">
									<ListItem name="LI_pNX_2144" order="363" ID="2144.100004300" title="pNX: Regional lymph nodes cannot be assessed" selected="true">
										<Property name="p_rptTxt_2144_1" order="364" propName="reportText" val="pNX" />
									</ListItem>
									<ListItem name="LI_pN0_2145" order="365" ID="2145.100004300" title="pN0: No regional lymph node metastasis">
										<Property name="p_rptTxt_2145_1" order="366" propName="reportText" val="pN0" />
									</ListItem>
									<ListItem name="LI_pN1_2146" order="367" ID="2146.100004300" title="pN1: Metastasis in regional lymph node(s)">
										<Property name="p_rptTxt_2146_1" order="368" propName="reportText" val="pN1" />
									</ListItem>
								</List>
							</ListField>
						</Question>
						<Question name="Q_pM_2149" order="369" ID="2149.100004300" title="?Distant Metastasis (pM) (Note I)">
							<Property name="p_rptTxt_2149_1" order="370" propName="reportText" val="Distant Metastasis (pM)" />
							<ListField name="lf_2149_2" order="371">
								<List name="lst_2149_3" order="372">
									<ListItem name="LI_NA_20895" order="373" ID="20895.100004300" title="?Not applicable - pM cannot be determined from the submitted specimen(s)" omitWhenSelected="true" selected="true">
										<Property name="p_rptTxt_20895_1" order="374" propName="reportText" val="Not applicable - pM cannot be determined from the submitted specimen(s)" />
									</ListItem>
									<ListItem name="LI_pM1_2151" order="375" ID="2151.100004300" title="pM1: Distant metastasis">
										<Property name="p_rptTxt_2151_1" order="376" propName="reportText" val="pM1" />
										<ChildItems name="ch_2151_2" order="377">
											<Question name="Q_pM_Loc_2152" order="378" ID="2152.100004300" title="?Specify Site(s), if known" minCard="0">
												<Property name="p_rptTxt_2152_1" order="379" propName="reportText" val="Site(s)" />
												<ResponseField name="rf_2152_2" order="380">
													<Response name="rsp_2152_3" order="381">
														<string name="str_2152_4" order="382" maxLength="4000" />
													</Response>
												</ResponseField>
											</Question>
										</ChildItems>
									</ListItem>
								</List>
							</ListField>
						</Question>
					</ChildItems>
				</Section>
				<Section name="S_17884" order="383" ID="17884.100004300" title="ADDITIONAL FINDINGS" mustImplement="false" minCard="0">
					<ChildItems name="ch_17884_1" order="384">
						<Question name="Q_39188" order="385" ID="39188.100004300" title="Additional Pathologic Findings" mustImplement="false" minCard="0">
							<ListField name="lf_39188_1" order="386" maxSelections="0">
								<List name="lst_39188_2" order="387">
									<ListItem name="LI_None_Id_2163" order="388" ID="2163.100004300" title="None identified" selectionDeselectsSiblings="true" />
									<ListItem name="LI_Hemorrhage_20897" order="389" ID="20897.100004300" title="Hemorrhage" />
									<ListItem name="LI_Cystic_Change_20898" order="390" ID="20898.100004300" title="Cystic change" />
									<ListItem name="LI_Calcifications_20854" order="391" ID="20854.100004300" title="Calcifications" />
									<ListItem name="LI_Oth_2167" order="392" ID="2167.100004300" title="Other (specify)">
										<Property name="p_rptTxt_2167_1" order="393" propName="reportText" val="{no text}" />
										<ListItemResponseField name="lirf_2167_2" order="394" responseRequired="true">
											<Response name="rsp_2167_3" order="395">
												<string name="str_2167_4" order="396" maxLength="4000" />
											</Response>
										</ListItemResponseField>
									</ListItem>
								</List>
							</ListField>
						</Question>
					</ChildItems>
				</Section>
				<Section name="S_17880" order="397" ID="17880.100004300" title="SPECIAL STUDIES" mustImplement="false" minCard="0">
					<ChildItems name="ch_17880_1" order="398">
						<Question name="Q_53231" order="399" ID="53231.100004300" title="Ancillary Studies (Note L)" mustImplement="false" minCard="0">
							<Property name="p_rptTxt_53231_1" order="400" propName="reportText" val="Ancillary Studies" />
							<ListField name="lf_53231_2" order="401" maxSelections="0">
								<List name="lst_53231_3" order="402">
									<ListItem name="LI_41352" order="403" ID="41352.100004300" title="Ki-67 mitotic rate (specify)">
										<Property name="p_rptTxt_41352_1" order="404" propName="reportText" val="Ki-67 mitotic rate" />
										<ListItemResponseField name="lirf_41352_2" order="405" responseRequired="true">
											<Response name="rsp_41352_3" order="406">
												<string name="str_41352_4" order="407" maxLength="4000" />
											</Response>
										</ListItemResponseField>
									</ListItem>
									<ListItem name="LI_54436" order="408" ID="54436.100004300" title="Reticulin stain (specify type(s) and result(s))">
										<Property name="p_rptTxt_54436_1" order="409" propName="reportText" val="Reticulin stain" />
										<ListItemResponseField name="lirf_54436_2" order="410" responseRequired="true">
											<Response name="rsp_54436_3" order="411">
												<string name="str_54436_4" order="412" maxLength="4000" />
											</Response>
										</ListItemResponseField>
									</ListItem>
									<ListItem name="LI_52023" order="413" ID="52023.100004300" title="Other (specify type and result)">
										<Property name="p_rptTxt_52023_1" order="414" propName="reportText" val="{no text}" />
										<ListItemResponseField name="lirf_52023_2" order="415" responseRequired="true">
											<Response name="rsp_52023_3" order="416">
												<string name="str_52023_4" order="417" maxLength="80" />
											</Response>
										</ListItemResponseField>
									</ListItem>
								</List>
							</ListField>
						</Question>
					</ChildItems>
				</Section>
				<Question name="Q_Comments_2168" order="418" ID="2168.100004300" title="?Comment(s)" minCard="0">
					<Property name="p_rptTxt_2168_1" order="419" propName="reportText" val="Comment(s)" />
					<ResponseField name="rf_2168_2" order="420">
						<Response name="rsp_2168_3" order="421">
							<string name="str_2168_4" order="422" maxLength="4000" val="this is a test for the IHE SDC WG " />
						</Response>
					</ResponseField>
				</Question>
			</ChildItems>
		</Body>
		<Footer name="footer" order="423" ID="Footer.Adrenal.Bx.Res.129_3.002.011.RC1_sdcFDF">
			<Property type="meta" styleClass="copyright" order="424" propName="CopyrightFooter" val="(c) 2018 College of American Pathologists.  All rights reserved.  License required for use." />
		</Footer>
	</FormDesign>
</SDCSubmissionPackage>"/>
        </presentedForm>
      </DiagnosticReport>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-section-specimen"/>
    <resource>
      <Observation>
        <id value="observation-section-specimen"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-section-specimen"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-section-specimen</b></p><a name="observation-section-specimen"> </a><a name="hcobservation-section-specimen"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:6ac70450-cc74-4a8e-8699-9ffab1e0ac24</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem SECTION}">Section</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 16182.100004300}">SPECIMEN</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>hasMember</b>: </p><ul><li><a href="Observation-observation-procedure-breast-excision.html">Observation Procedure (Note A)</a></li><li><a href="Observation-observation-specimen-laterality.html">Observation Specimen Laterality</a></li></ul></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:6ac70450-cc74-4a8e-8699-9ffab1e0ac24"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="SECTION"/>
            <display value="Section"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="16182.100004300"/>
            <display value="SPECIMEN"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectiveDateTime value="2025-03-18"/>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <hasMember>🔗 
          <reference
                     value="Observation/observation-procedure-breast-excision"/>
        </hasMember>
        <hasMember>🔗 
          <reference value="Observation/observation-specimen-laterality"/>
        </hasMember>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-section-tumor"/>
    <resource>
      <Observation>
        <id value="observation-section-tumor"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-section-tumor"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-section-tumor</b></p><a name="observation-section-tumor"> </a><a name="hcobservation-section-tumor"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:cb7657fb-8127-41ef-9912-8f6fc52a5f85</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem SECTION}">Section</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 16249.100004300}">TUMOR</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2024-12-05</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>hasMember</b>: </p><ul><li><a href="Observation-observation-tumor-site.html">Observation Tumor Site (Note B)</a></li><li><a href="Observation-observation-histologic-type.html">Observation Histologic Type (Note C)</a></li><li><a href="Observation-observation-histologic-grade.html">Observation Histologic Grade (Nottingham Histologic Score) (required only if applicable) (Note D)</a></li><li><a href="Observation-observation-tumor-size.html">Observation Tumor Size (Note E)</a></li><li><a href="Observation-observation-tumor-focality.html">Observation Tumor Focality (Note F)</a></li><li><a href="Observation-observation-ductal-carcinoma.html">Observation Ductal Carcinoma In Situ (DCIS) (Note G)</a></li></ul></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:cb7657fb-8127-41ef-9912-8f6fc52a5f85"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="SECTION"/>
            <display value="Section"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="16249.100004300"/>
            <display value="TUMOR"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectiveDateTime value="2024-12-05"/>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <hasMember>🔗 
          <reference value="Observation/observation-tumor-site"/>
        </hasMember>
        <hasMember>🔗 
          <reference value="Observation/observation-histologic-type"/>
        </hasMember>
        <hasMember>🔗 
          <reference value="Observation/observation-histologic-grade"/>
        </hasMember>
        <hasMember>🔗 
          <reference value="Observation/observation-tumor-size"/>
        </hasMember>
        <hasMember>🔗 
          <reference value="Observation/observation-tumor-focality"/>
        </hasMember>
        <hasMember>🔗 
          <reference value="Observation/observation-ductal-carcinoma"/>
        </hasMember>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-section-lymph-nodes"/>
    <resource>
      <Observation>
        <id value="observation-section-lymph-nodes"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-section-lymph-nodes"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-section-lymph-nodes</b></p><a name="observation-section-lymph-nodes"> </a><a name="hcobservation-section-lymph-nodes"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem SECTION}">Section</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 868263.100004300}">Lymph Nodes</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="SECTION"/>
            <display value="Section"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="868263.100004300"/>
            <display value="Lymph Nodes"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectiveDateTime value="2025-03-18"/>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-section-margins"/>
    <resource>
      <Observation>
        <id value="observation-section-margins"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-section-margins"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-section-margins</b></p><a name="observation-section-margins"> </a><a name="hcobservation-section-margins"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem SECTION}">Section</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 16567.100004300}">MARGINS (Note L)</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>hasMember</b>: <a href="Observation-observation-margins-margin-status-for-invasive-carcinoma.html">Observation Margin Status for Invasive Carcinoma</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="SECTION"/>
            <display value="Section"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="16567.100004300"/>
            <display value="MARGINS (Note L)"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectiveDateTime value="2025-03-18"/>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <hasMember>🔗 
          <reference
                     value="Observation/observation-margins-margin-status-for-invasive-carcinoma"/>
        </hasMember>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-section-regional-lymph-nodes"/>
    <resource>
      <Observation>
        <id value="observation-section-regional-lymph-nodes"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-section-regional-lymph-nodes"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-section-regional-lymph-nodes</b></p><a name="observation-section-regional-lymph-nodes"> </a><a name="hcobservation-section-regional-lymph-nodes"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem SECTION}">Section</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 16697.100004300}">REGIONAL LYMPH NODES (Note M)</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>hasMember</b>: <a href="Observation-observation-regional-lymph-node-status.html">Observation Regional Lymph Node Status</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="SECTION"/>
            <display value="Section"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="16697.100004300"/>
            <display value="REGIONAL LYMPH NODES (Note M)"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectiveDateTime value="2025-03-18"/>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <hasMember>🔗 
          <reference
                     value="Observation/observation-regional-lymph-node-status"/>
        </hasMember>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-section-distant-metastasis"/>
    <resource>
      <Observation>
        <id value="observation-section-distant-metastasis"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-section-distant-metastasis"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-section-distant-metastasis</b></p><a name="observation-section-distant-metastasis"> </a><a name="hcobservation-section-distant-metastasis"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem SECTION}">Section</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 352333.100004300}">Distant Metastasis</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>hasMember</b>: <a href="Observation-observation-distant-metastasis.html">Observation DISTANT METASTASIS</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="SECTION"/>
            <display value="Section"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="352333.100004300"/>
            <display value="Distant Metastasis"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectiveDateTime value="2025-03-18"/>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <hasMember>🔗 
          <reference value="Observation/observation-distant-metastasis"/>
        </hasMember>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-section-ptnm-classification"/>
    <resource>
      <Observation>
        <id value="observation-section-ptnm-classification"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-section-ptnm-classification"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-section-ptnm-classification</b></p><a name="observation-section-ptnm-classification"> </a><a name="hcobservation-section-ptnm-classification"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:4958b036-f88e-470b-b225-38e9fe6b6541</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem SECTION}">Section</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 16717.100004300}">PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition) (Note M)</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>hasMember</b>: </p><ul><li><a href="Observation-observation-ptnm-classification-pT-Category.html">Observation pT Category</a></li><li><a href="Observation-observation-ptnm-classification-pN-Category.html">Observation pN Category</a></li></ul></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:4958b036-f88e-470b-b225-38e9fe6b6541"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="SECTION"/>
            <display value="Section"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="16717.100004300"/>
            <display
                     value="PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition) (Note M)"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectiveDateTime value="2025-03-18"/>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <hasMember>🔗 
          <reference
                     value="Observation/observation-ptnm-classification-pT-Category"/>
        </hasMember>
        <hasMember>🔗 
          <reference
                     value="Observation/observation-ptnm-classification-pN-Category"/>
        </hasMember>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-section-additional-findings"/>
    <resource>
      <Observation>
        <id value="observation-section-additional-findings"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-section-additional-findings"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-section-additional-findings</b></p><a name="observation-section-additional-findings"> </a><a name="hcobservation-section-additional-findings"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:7c9139fe-ddd5-49d9-b649-f37344e8b995</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem SECTION}">Section</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 16782.100004300}">ADDITIONAL FINDINGS (Note N)</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>hasMember</b>: <a href="Observation-observation-additional-findings-specify.html">Observation Additional Findings (specify)</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:7c9139fe-ddd5-49d9-b649-f37344e8b995"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="SECTION"/>
            <display value="Section"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="16782.100004300"/>
            <display value="ADDITIONAL FINDINGS (Note N)"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectiveDateTime value="2025-03-18"/>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <hasMember>🔗 
          <reference
                     value="Observation/observation-additional-findings-specify"/>
        </hasMember>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-additional-findings-specify"/>
    <resource>
      <Observation>
        <id value="observation-additional-findings-specify"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-additional-findings-specify"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-additional-findings-specify</b></p><a name="observation-additional-findings-specify"> </a><a name="hcobservation-additional-findings-specify"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:9cfaa1f6-f0af-4e66-8fe0-130b2143b135</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 16783.100004300}">Additional Findings (specify)</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>derivedFrom</b>: <a href="Observation-observation-section-additional-findings.html">Observation ADDITIONAL FINDINGS (Note N)</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:9cfaa1f6-f0af-4e66-8fe0-130b2143b135"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="16783.100004300"/>
            <display value="Additional Findings (specify)"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectiveDateTime value="2025-03-18"/>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <derivedFrom>🔗 
          <reference
                     value="Observation/observation-section-additional-findings"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-section-special-studies"/>
    <resource>
      <Observation>
        <id value="observation-section-special-studies"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-section-special-studies"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-section-special-studies</b></p><a name="observation-section-special-studies"> </a><a name="hcobservation-section-special-studies"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:87335ed1-f468-4061-a401-8b8e3b54cf4c</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem SECTION}">Section</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 17834.100004300}">SPECIAL STUDIES</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>hasMember</b>: <a href="Observation-observation-special-studies-breast-biomarker.html">Observation Breast Biomarker Testing Performed on Previous Biopsy</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:87335ed1-f468-4061-a401-8b8e3b54cf4c"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="SECTION"/>
            <display value="Section"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="17834.100004300"/>
            <display value="SPECIAL STUDIES"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectiveDateTime value="2025-03-18"/>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <hasMember>🔗 
          <reference
                     value="Observation/observation-special-studies-breast-biomarker"/>
        </hasMember>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-section-comments"/>
    <resource>
      <Observation>
        <id value="observation-section-comments"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-section-comments"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-section-comments</b></p><a name="observation-section-comments"> </a><a name="hcobservation-section-comments"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/uuid:c3189cd4-33a0-447f-9bbf-2b225e2aa305</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem SECTION}">Section</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 381061.100004300}">COMMENTS</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="uuid:c3189cd4-33a0-447f-9bbf-2b225e2aa305"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="SECTION"/>
            <display value="Section"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="381061.100004300"/>
            <display value="COMMENTS"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectiveDateTime value="2025-03-18"/>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-procedure-breast-excision"/>
    <resource>
      <Observation>
        <id value="observation-procedure-breast-excision"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-procedure-breast-excision"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-procedure-breast-excision</b></p><a name="observation-procedure-breast-excision"> </a><a name="hcobservation-procedure-breast-excision"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:7c9139fe-ddd5-49d9-b649-f37344e8b995</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 58807.100004300}, {http://snomed.info/sct 2620001000004108}">Procedure (Note A)</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18 14:52:02+0000 --&gt; (ongoing)</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>value</b>: <span title="Codes:{http://cap.org/eCC 40307.100004300}, {http://snomed.info/sct 1231734007}">Excision (less than total mastectomy)</span></p><p><b>derivedFrom</b>: <a href="Observation-observation-section-specimen.html">Observation SPECIMEN</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:7c9139fe-ddd5-49d9-b649-f37344e8b995"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="58807.100004300"/>
            <display value="Procedure (Note A)"/>
          </coding>
          <coding>
            <system value="http://snomed.info/sct"/>
            <code value="2620001000004108"/>
            <display
                     value="Specimen collection procedure (observable entity)"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectivePeriod>
          <start value="2025-03-18T14:52:02+00:00"/>
        </effectivePeriod>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <valueCodeableConcept>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="40307.100004300"/>
            <display value="Excision (less than total mastectomy)"/>
          </coding>
          <coding>
            <system value="http://snomed.info/sct"/>
            <code value="1231734007"/>
            <display value="Excision of breast (procedure)"/>
          </coding>
        </valueCodeableConcept>
        <derivedFrom>🔗 
          <reference value="Observation/observation-section-specimen"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-specimen-laterality"/>
    <resource>
      <Observation>
        <id value="observation-specimen-laterality"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-specimen-laterality"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-specimen-laterality</b></p><a name="observation-specimen-laterality"> </a><a name="hcobservation-specimen-laterality"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:4bcd147c-ff3d-4eb3-bcd3-9d679bd1ad1b</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 16214.100004300}">Specimen Laterality</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18 14:52:02+0000 --&gt; (ongoing)</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>value</b>: <span title="Codes:{http://cap.org/eCC 16215.100004300}, {http://snomed.info/sct 73056007}">Right</span></p><p><b>derivedFrom</b>: <a href="Observation-observation-section-specimen.html">Observation SPECIMEN</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:4bcd147c-ff3d-4eb3-bcd3-9d679bd1ad1b"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="16214.100004300"/>
            <display value="Specimen Laterality"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectivePeriod>
          <start value="2025-03-18T14:52:02+00:00"/>
        </effectivePeriod>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <valueCodeableConcept>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="16215.100004300"/>
            <display value="Right"/>
          </coding>
          <coding>
            <system value="http://snomed.info/sct"/>
            <code value="73056007"/>
            <display value="Right breast structure (body structure)"/>
          </coding>
        </valueCodeableConcept>
        <derivedFrom>🔗 
          <reference value="Observation/observation-section-specimen"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-tumor-site"/>
    <resource>
      <Observation>
        <id value="observation-tumor-site"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-tumor-site"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-tumor-site</b></p><a name="observation-tumor-site"> </a><a name="hcobservation-tumor-site"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:79ab15c8-4b0e-48e5-a477-7f72e62c002b</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 51180.100004300}, {http://snomed.info/sct 399687005}">Tumor Site (Note B)</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18 14:52:02+0000 --&gt; (ongoing)</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>hasMember</b>: <a href="Observation-observation-clock-position.html">Observation Clock position</a></p><p><b>derivedFrom</b>: <a href="Observation-observation-section-tumor.html">Observation TUMOR</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:79ab15c8-4b0e-48e5-a477-7f72e62c002b"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="51180.100004300"/>
            <display value="Tumor Site (Note B)"/>
          </coding>
          <coding>
            <system value="http://snomed.info/sct"/>
            <code value="399687005"/>
            <display
                     value="Anatomic location of primary malignant neoplasm (observable entity)"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectivePeriod>
          <start value="2025-03-18T14:52:02+00:00"/>
        </effectivePeriod>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <hasMember>🔗 
          <reference value="Observation/observation-clock-position"/>
        </hasMember>
        <derivedFrom>🔗 
          <reference value="Observation/observation-section-tumor"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-clock-position"/>
    <resource>
      <Observation>
        <id value="observation-clock-position"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-clock-position"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-clock-position</b></p><a name="observation-clock-position"> </a><a name="hcobservation-clock-position"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:ab9326c2-e1fe-4ba0-873c-41c923c7f772</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 51180.100004300}, {http://snomed.info/sct 399687005}">Clock position</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18 14:52:02+0000 --&gt; (ongoing)</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>value</b>: <span title="Codes:{http://cap.org/eCC 42418.100004300}">Clock position</span></p><p><b>hasMember</b>: <a href="Observation-observation-clock-position-8.html">Observation Specify Clock Position</a></p><p><b>derivedFrom</b>: <a href="Observation-observation-tumor-site.html">Observation Tumor Site (Note B)</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:ab9326c2-e1fe-4ba0-873c-41c923c7f772"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="51180.100004300"/>
            <display value="Clock position"/>
          </coding>
          <coding>
            <system value="http://snomed.info/sct"/>
            <code value="399687005"/>
            <display
                     value="Anatomic location of primary malignant neoplasm (observable entity)"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectivePeriod>
          <start value="2025-03-18T14:52:02+00:00"/>
        </effectivePeriod>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <valueCodeableConcept>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="42418.100004300"/>
            <display value="Clock position"/>
          </coding>
        </valueCodeableConcept>
        <hasMember>🔗 
          <reference value="Observation/observation-clock-position-8"/>
        </hasMember>
        <derivedFrom>🔗 
          <reference value="Observation/observation-tumor-site"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-clock-position-8"/>
    <resource>
      <Observation>
        <id value="observation-clock-position-8"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-clock-position-8"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-clock-position-8</b></p><a name="observation-clock-position-8"> </a><a name="hcobservation-clock-position-8"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:bf778f95-b1a8-4674-a73e-1f2dc0bfbdc4</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 16259.100004300}, {http://snomed.info/sct 3980001000004105}">Specify Clock Position</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-13 14:52:02+0000 --&gt; (ongoing)</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>value</b>: <span title="Codes:{http://cap.org/eCC 6643.100004300}, {http://snomed.info/sct 260341007}">8 o'clock</span></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:bf778f95-b1a8-4674-a73e-1f2dc0bfbdc4"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="16259.100004300"/>
            <display value="Specify Clock Position"/>
          </coding>
          <coding>
            <system value="http://snomed.info/sct"/>
            <code value="3980001000004105"/>
            <display
                     value="Radial location of primary malignant neoplasm in excised breast specimen (observable entity)"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectivePeriod>
          <start value="2025-03-13T14:52:02+00:00"/>
        </effectivePeriod>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <valueCodeableConcept>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="6643.100004300"/>
            <display value="8 o'clock"/>
          </coding>
          <coding>
            <system value="http://snomed.info/sct"/>
            <code value="260341007"/>
            <display value="8 o'clock position (qualifier value)"/>
          </coding>
        </valueCodeableConcept>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-histologic-type"/>
    <resource>
      <Observation>
        <id value="observation-histologic-type"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-histologic-type"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-histologic-type</b></p><a name="observation-histologic-type"> </a><a name="hcobservation-histologic-type"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:cb7657fb-8127-41ef-9912-8f6fc52a5f85</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 41794.100004300}">Histologic Type (Note C)</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>value</b>: <span title="Codes:{http://cap.org/eCC 16280.100004300}">Invasive carcinoma of no special type (ductal)</span></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:cb7657fb-8127-41ef-9912-8f6fc52a5f85"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="41794.100004300"/>
            <display value="Histologic Type (Note C)"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectiveDateTime value="2025-03-18"/>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <valueCodeableConcept>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="16280.100004300"/>
            <display value="Invasive carcinoma of no special type (ductal)"/>
          </coding>
        </valueCodeableConcept>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-histologic-grade"/>
    <resource>
      <Observation>
        <id value="observation-histologic-grade"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-histologic-grade"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-histologic-grade</b></p><a name="observation-histologic-grade"> </a><a name="hcobservation-histologic-grade"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:cb7657fb-8127-41ef-9912-8f6fc52a5f85</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 380281.100004300}">Histologic Grade (Nottingham Histologic Score) (required only if applicable) (Note D)</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18 14:52:02+0000 --&gt; (ongoing)</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>value</b>: <span title="Codes:{http://cap.org/eCC 380283.100004300}">Nottingham Score</span></p><p><b>hasMember</b>: </p><ul><li><a href="Observation-observation-glandular-differentiation.html">Observation Glandular (Acinar) / Tubular Differentiation</a></li><li><a href="Observation-observation-nuclear-pleomorphism.html">Observation Nuclear Pleomorphism</a></li><li><a href="Observation-observation-mitotic-rate.html">Observation Mitotic Rate</a></li><li><a href="Observation-observation-overall-grade.html">Observation Overall Grade</a></li></ul><p><b>derivedFrom</b>: <a href="Observation-observation-section-tumor.html">Observation TUMOR</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:cb7657fb-8127-41ef-9912-8f6fc52a5f85"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="380281.100004300"/>
            <display
                     value="Histologic Grade (Nottingham Histologic Score) (required only if applicable) (Note D)"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectivePeriod>
          <start value="2025-03-18T14:52:02+00:00"/>
        </effectivePeriod>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <valueCodeableConcept>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="380283.100004300"/>
            <display value="Nottingham Score"/>
          </coding>
        </valueCodeableConcept>
        <hasMember>🔗 
          <reference
                     value="Observation/observation-glandular-differentiation"/>
        </hasMember>
        <hasMember>🔗 
          <reference value="Observation/observation-nuclear-pleomorphism"/>
        </hasMember>
        <hasMember>🔗 
          <reference value="Observation/observation-mitotic-rate"/>
        </hasMember>
        <hasMember>🔗 
          <reference value="Observation/observation-overall-grade"/>
        </hasMember>
        <derivedFrom>🔗 
          <reference value="Observation/observation-section-tumor"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-glandular-differentiation"/>
    <resource>
      <Observation>
        <id value="observation-glandular-differentiation"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-glandular-differentiation"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-glandular-differentiation</b></p><a name="observation-glandular-differentiation"> </a><a name="hcobservation-glandular-differentiation"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:f0d0b23b-f6a0-44d4-bfaf-ade1b485c0b0</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 38124.100004300}">Glandular (Acinar) / Tubular Differentiation</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18 14:52:02+0000 --&gt; (ongoing)</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>value</b>: <span title="Codes:{http://cap.org/eCC 16348.100004300}">Score 2 (10 to 75% of tumor area forming glandular / tubular structures)</span></p><p><b>derivedFrom</b>: <a href="Observation-observation-histologic-grade.html">Observation Histologic Grade (Nottingham Histologic Score) (required only if applicable) (Note D)</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:f0d0b23b-f6a0-44d4-bfaf-ade1b485c0b0"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="38124.100004300"/>
            <display value="Glandular (Acinar) / Tubular Differentiation"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectivePeriod>
          <start value="2025-03-18T14:52:02+00:00"/>
        </effectivePeriod>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <valueCodeableConcept>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="16348.100004300"/>
            <display
                     value="Score 2 (10 to 75% of tumor area forming glandular / tubular structures)"/>
          </coding>
        </valueCodeableConcept>
        <derivedFrom>🔗 
          <reference value="Observation/observation-histologic-grade"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-nuclear-pleomorphism"/>
    <resource>
      <Observation>
        <id value="observation-nuclear-pleomorphism"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-nuclear-pleomorphism"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-nuclear-pleomorphism</b></p><a name="observation-nuclear-pleomorphism"> </a><a name="hcobservation-nuclear-pleomorphism"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:77d0563d-3685-4316-9a81-fa7d04d0d8d2</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 38125.100004300}">Nuclear Pleomorphism</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18 14:52:02+0000 --&gt; (ongoing)</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>value</b>: <span title="Codes:{http://cap.org/eCC 16355.100004300}">Score 2 (Cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate variability in both size and shape)</span></p><p><b>derivedFrom</b>: <a href="Observation-observation-histologic-grade.html">Observation Histologic Grade (Nottingham Histologic Score) (required only if applicable) (Note D)</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:77d0563d-3685-4316-9a81-fa7d04d0d8d2"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="38125.100004300"/>
            <display value="Nuclear Pleomorphism"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectivePeriod>
          <start value="2025-03-18T14:52:02+00:00"/>
        </effectivePeriod>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <valueCodeableConcept>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="16355.100004300"/>
            <display
                     value="Score 2 (Cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate variability in both size and shape)"/>
          </coding>
        </valueCodeableConcept>
        <derivedFrom>🔗 
          <reference value="Observation/observation-histologic-grade"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-mitotic-rate"/>
    <resource>
      <Observation>
        <id value="observation-mitotic-rate"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-mitotic-rate"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-mitotic-rate</b></p><a name="observation-mitotic-rate"> </a><a name="hcobservation-mitotic-rate"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:814dd523-9284-4edb-8831-fc1c440e4979</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 38390.100004300}">Mitotic Rate</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18 14:52:02+0000 --&gt; (ongoing)</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>value</b>: <span title="Codes:{http://cap.org/eCC 16383.100004300}">Score 1</span></p><p><b>derivedFrom</b>: <a href="Observation-observation-histologic-grade.html">Observation Histologic Grade (Nottingham Histologic Score) (required only if applicable) (Note D)</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:814dd523-9284-4edb-8831-fc1c440e4979"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="38390.100004300"/>
            <display value="Mitotic Rate"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectivePeriod>
          <start value="2025-03-18T14:52:02+00:00"/>
        </effectivePeriod>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <valueCodeableConcept>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="16383.100004300"/>
            <display value="Score 1"/>
          </coding>
        </valueCodeableConcept>
        <derivedFrom>🔗 
          <reference value="Observation/observation-histologic-grade"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-overall-grade"/>
    <resource>
      <Observation>
        <id value="observation-overall-grade"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-overall-grade"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-overall-grade</b></p><a name="observation-overall-grade"> </a><a name="hcobservation-overall-grade"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:ddea4bbc-a3e7-477b-b279-57cf5071e0b9</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 38391.100004300}">Overall Grade</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2024-12-05 14:52:02+0000 --&gt; (ongoing)</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>value</b>: <span title="Codes:{http://cap.org/eCC 16390.100004300}">Grade 1 (scores of 3, 4 or 5)</span></p><p><b>derivedFrom</b>: <a href="Observation-observation-histologic-grade.html">Observation Histologic Grade (Nottingham Histologic Score) (required only if applicable) (Note D)</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:ddea4bbc-a3e7-477b-b279-57cf5071e0b9"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="38391.100004300"/>
            <display value="Overall Grade"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectivePeriod>
          <start value="2024-12-05T14:52:02+00:00"/>
        </effectivePeriod>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <valueCodeableConcept>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="16390.100004300"/>
            <display value="Grade 1 (scores of 3, 4 or 5)"/>
          </coding>
        </valueCodeableConcept>
        <derivedFrom>🔗 
          <reference value="Observation/observation-histologic-grade"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-tumor-size"/>
    <resource>
      <Observation>
        <id value="observation-tumor-size"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-tumor-size"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-tumor-size</b></p><a name="observation-tumor-size"> </a><a name="hcobservation-tumor-size"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:66153175-f304-443e-99cb-4058f350248b</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 30148.100004300}">Tumor Size (Note E)</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley</a></p><p><b>effective</b>: 2025-03-18 14:52:02+0000 --&gt; (ongoing)</p><p><b>performer</b>: <a href="PractitionerRole-practitionerrole-uspath-pathologist.html">PractitionerRole Primary Interpreter</a></p><p><b>value</b>: <span title="Codes:{http://cap.org/eCC 31357.100004300}, {http://snomed.info/sct 200001000004104}">Greatest dimension of largest invasive focus greater than 1 mm (specify exact measurement in Millimeters (mm))</span></p><p><b>hasMember</b>: <a href="Observation-observation-additional-dimension.html">Observation Additional Dimension in Millimeters (mm)</a></p><p><b>derivedFrom</b>: <a href="Observation-observation-section-tumor.html">Observation TUMOR</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:66153175-f304-443e-99cb-4058f350248b"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="30148.100004300"/>
            <display value="Tumor Size (Note E)"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
          <display value="Annie Oakley"/>
        </subject>
        <effectivePeriod>
          <start value="2025-03-18T14:52:02+00:00"/>
        </effectivePeriod>
        <performer>🔗 
          <reference
                     value="PractitionerRole/practitionerrole-uspath-pathologist"/>
        </performer>
        <valueCodeableConcept>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="31357.100004300"/>
            <display
                     value="Greatest dimension of largest invasive focus greater than 1 mm (specify exact measurement in Millimeters (mm))"/>
          </coding>
          <coding>
            <system value="http://snomed.info/sct"/>
            <code value="200001000004104"/>
            <display
                     value="Greatest length dimension of excised primary malignant neoplasm (observable entity)"/>
          </coding>
        </valueCodeableConcept>
        <hasMember>🔗 
          <reference value="Observation/observation-additional-dimension"/>
        </hasMember>
        <derivedFrom>🔗 
          <reference value="Observation/observation-section-tumor"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-additional-dimension"/>
    <resource>
      <Observation>
        <id value="observation-additional-dimension"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-additional-dimension"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-additional-dimension</b></p><a name="observation-additional-dimension"> </a><a name="hcobservation-additional-dimension"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:18c9ea9c-ddf2-400d-adea-07c97dd7b016</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 31359.100004300}">Additional Dimension in Millimeters (mm)</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18 14:52:02+0000 --&gt; (ongoing)</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>value</b>: 13</p><p><b>derivedFrom</b>: <a href="Observation-observation-tumor-size.html">Observation Tumor Size (Note E)</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:18c9ea9c-ddf2-400d-adea-07c97dd7b016"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="31359.100004300"/>
            <display value="Additional Dimension in Millimeters (mm)"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectivePeriod>
          <start value="2025-03-18T14:52:02+00:00"/>
        </effectivePeriod>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <valueQuantity>
          <value value="13"/>
        </valueQuantity>
        <derivedFrom>🔗 
          <reference value="Observation/observation-tumor-size"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-tumor-focality"/>
    <resource>
      <Observation>
        <id value="observation-tumor-focality"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-tumor-focality"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-tumor-focality</b></p><a name="observation-tumor-focality"> </a><a name="hcobservation-tumor-focality"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:309f8a1c-8311-4751-8718-4b2573a09633</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 38392.100004300}">Tumor Focality (Note F)</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18 14:52:02+0000 --&gt; (ongoing)</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>value</b>: <span title="Codes:{http://cap.org/eCC 16448.100004300}">Single focus of invasive carcinoma</span></p><p><b>derivedFrom</b>: <a href="Observation-observation-section-tumor.html">Observation TUMOR</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:309f8a1c-8311-4751-8718-4b2573a09633"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="38392.100004300"/>
            <display value="Tumor Focality (Note F)"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectivePeriod>
          <start value="2025-03-18T14:52:02+00:00"/>
        </effectivePeriod>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <valueCodeableConcept>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="16448.100004300"/>
            <display value="Single focus of invasive carcinoma"/>
          </coding>
        </valueCodeableConcept>
        <derivedFrom>🔗 
          <reference value="Observation/observation-section-tumor"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-ductal-carcinoma"/>
    <resource>
      <Observation>
        <id value="observation-ductal-carcinoma"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-ductal-carcinoma"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-ductal-carcinoma</b></p><a name="observation-ductal-carcinoma"> </a><a name="hcobservation-ductal-carcinoma"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:c2f916f9-7438-4ba6-9cba-9e9064edbe3c</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 44040.100004300}">Ductal Carcinoma In Situ (DCIS) (Note G)</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18 14:52:02+0000 --&gt; (ongoing)</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>value</b>: <span title="Codes:{http://cap.org/eCC 16306.100004300}, {http://snomed.info/sct 47492008}">Not identified</span></p><p><b>derivedFrom</b>: <a href="Observation-observation-section-tumor.html">Observation TUMOR</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:c2f916f9-7438-4ba6-9cba-9e9064edbe3c"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="44040.100004300"/>
            <display value="Ductal Carcinoma In Situ (DCIS) (Note G)"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectivePeriod>
          <start value="2025-03-18T14:52:02+00:00"/>
        </effectivePeriod>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <valueCodeableConcept>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="16306.100004300"/>
            <display value="Not identified"/>
          </coding>
          <coding>
            <system value="http://snomed.info/sct"/>
            <code value="47492008"/>
            <display value="Not seen (qualifier value)"/>
          </coding>
        </valueCodeableConcept>
        <derivedFrom>🔗 
          <reference value="Observation/observation-section-tumor"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-section-tumor-extent"/>
    <resource>
      <Observation>
        <id value="observation-section-tumor-extent"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-section-tumor-extent"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-section-tumor-extent</b></p><a name="observation-section-tumor-extent"> </a><a name="hcobservation-section-tumor-extent"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:1dc64a64-e4f1-4996-87df-28b76446c35a</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem SECTION}">Section</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 16403.100004300}">Tumor Extent (Note H)</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18 14:52:02+0000 --&gt; (ongoing)</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>derivedFrom</b>: <a href="Observation-observation-section-tumor.html">Observation TUMOR</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:1dc64a64-e4f1-4996-87df-28b76446c35a"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="SECTION"/>
            <display value="Section"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="16403.100004300"/>
            <display value="Tumor Extent (Note H)"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectivePeriod>
          <start value="2025-03-18T14:52:02+00:00"/>
        </effectivePeriod>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <derivedFrom>🔗 
          <reference value="Observation/observation-section-tumor"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-margins-margin-status-for-invasive-carcinoma"/>
    <resource>
      <Observation>
        <id value="observation-margins-margin-status-for-invasive-carcinoma"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-margins-margin-status-for-invasive-carcinoma"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-margins-margin-status-for-invasive-carcinoma</b></p><a name="observation-margins-margin-status-for-invasive-carcinoma"> </a><a name="hcobservation-margins-margin-status-for-invasive-carcinoma"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:ee170d9a-d5b5-481a-ac58-52dea11955b4</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 351503.100004300}">Margin Status for Invasive Carcinoma</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18 14:52:02+0000 --&gt; (ongoing)</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>value</b>: <span title="Codes:{http://cap.org/eCC 351504.100004300}">All margins negative for invasive carcinoma</span></p><p><b>hasMember</b>: </p><ul><li><a href="Observation-observation-margins-distance-to-closest-margin.html">Observation Distance from Invasive Carcinoma to Closest Margin</a></li><li><a href="Observation-observation-margins-closest-margin-to-invasive-carcinoma.html">Observation Closest Margin(s) to Invasive Carcinoma</a></li></ul><p><b>derivedFrom</b>: <a href="Observation-observation-section-margins.html">Observation MARGINS (Note L)</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:ee170d9a-d5b5-481a-ac58-52dea11955b4"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="351503.100004300"/>
            <display value="Margin Status for Invasive Carcinoma"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectivePeriod>
          <start value="2025-03-18T14:52:02+00:00"/>
        </effectivePeriod>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <valueCodeableConcept>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="351504.100004300"/>
            <display value="All margins negative for invasive carcinoma"/>
          </coding>
        </valueCodeableConcept>
        <hasMember>🔗 
          <reference
                     value="Observation/observation-margins-distance-to-closest-margin"/>
        </hasMember>
        <hasMember>🔗 
          <reference
                     value="Observation/observation-margins-closest-margin-to-invasive-carcinoma"/>
        </hasMember>
        <derivedFrom>🔗 
          <reference value="Observation/observation-section-margins"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-margins-distance-to-closest-margin"/>
    <resource>
      <Observation>
        <id value="observation-margins-distance-to-closest-margin"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-margins-distance-to-closest-margin"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-margins-distance-to-closest-margin</b></p><a name="observation-margins-distance-to-closest-margin"> </a><a name="hcobservation-margins-distance-to-closest-margin"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:7069b59e-9414-4838-bd6d-674ef97c414c</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 351503.100004300}">Distance from Invasive Carcinoma to Closest Margin</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18 14:52:02+0000 --&gt; (ongoing)</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>value</b>: <span title="Codes:{http://cap.org/eCC 16448.100004300}">Exact distance</span></p><p><b>derivedFrom</b>: <a href="Observation-observation-margins-margin-status-for-invasive-carcinoma.html">Observation Margin Status for Invasive Carcinoma</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:7069b59e-9414-4838-bd6d-674ef97c414c"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="351503.100004300"/>
            <display
                     value="Distance from Invasive Carcinoma to Closest Margin"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectivePeriod>
          <start value="2025-03-18T14:52:02+00:00"/>
        </effectivePeriod>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <valueCodeableConcept>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="16448.100004300"/>
            <display value="Exact distance"/>
          </coding>
        </valueCodeableConcept>
        <derivedFrom>🔗 
          <reference
                     value="Observation/observation-margins-margin-status-for-invasive-carcinoma"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-margins-closest-margin-to-invasive-carcinoma"/>
    <resource>
      <Observation>
        <id value="observation-margins-closest-margin-to-invasive-carcinoma"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-margins-closest-margin-to-invasive-carcinoma"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-margins-closest-margin-to-invasive-carcinoma</b></p><a name="observation-margins-closest-margin-to-invasive-carcinoma"> </a><a name="hcobservation-margins-closest-margin-to-invasive-carcinoma"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:c12982a8-541c-469a-b016-9468d58eb858</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 351503.100004300}">Closest Margin(s) to Invasive Carcinoma</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18 14:52:02+0000 --&gt; (ongoing)</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>value</b>: <span title="Codes:{http://cap.org/eCC 351501.100004300}">Lateral</span></p><p><b>derivedFrom</b>: <a href="Observation-observation-section-margins.html">Observation MARGINS (Note L)</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:c12982a8-541c-469a-b016-9468d58eb858"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="351503.100004300"/>
            <display value="Closest Margin(s) to Invasive Carcinoma"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectivePeriod>
          <start value="2025-03-18T14:52:02+00:00"/>
        </effectivePeriod>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <valueCodeableConcept>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="351501.100004300"/>
            <display value="Lateral"/>
          </coding>
        </valueCodeableConcept>
        <derivedFrom>🔗 
          <reference value="Observation/observation-section-margins"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-regional-lymph-node-status"/>
    <resource>
      <Observation>
        <id value="observation-regional-lymph-node-status"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-regional-lymph-node-status"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-regional-lymph-node-status</b></p><a name="observation-regional-lymph-node-status"> </a><a name="hcobservation-regional-lymph-node-status"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 351589.100004300}">Regional Lymph Node Status</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>value</b>: <span title="Codes:{http://cap.org/eCC 374353.100004300}">Regional lymph nodes present</span></p><p><b>hasMember</b>: </p><ul><li><a href="Observation-observation-regional-lymph-nodes-number-examined.html">Observation Total Number of Lymph Nodes Examined (sentinel and non-sentinel)</a></li><li><a href="Observation-observation-regional-lymph-nodes-number-sentinel.html">Observation Number of Sentinel Nodes Examined</a></li></ul><p><b>derivedFrom</b>: <a href="Observation-observation-section-regional-lymph-nodes.html">Observation REGIONAL LYMPH NODES (Note M)</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="351589.100004300"/>
            <display value="Regional Lymph Node Status"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectiveDateTime value="2025-03-18"/>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <valueCodeableConcept>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="374353.100004300"/>
            <display value="Regional lymph nodes present"/>
          </coding>
        </valueCodeableConcept>
        <hasMember>🔗 
          <reference
                     value="Observation/observation-regional-lymph-nodes-number-examined"/>
        </hasMember>
        <hasMember>🔗 
          <reference
                     value="Observation/observation-regional-lymph-nodes-number-sentinel"/>
        </hasMember>
        <derivedFrom>🔗 
          <reference
                     value="Observation/observation-section-regional-lymph-nodes"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-regional-lymph-nodes-number-examined"/>
    <resource>
      <Observation>
        <id value="observation-regional-lymph-nodes-number-examined"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-regional-lymph-nodes-number-examined"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-regional-lymph-nodes-number-examined</b></p><a name="observation-regional-lymph-nodes-number-examined"> </a><a name="hcobservation-regional-lymph-nodes-number-examined"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:a903ae85-913a-4c9b-94cb-c6a1e00340e3</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 351602.100004300}">Total Number of Lymph Nodes Examined (sentinel and non-sentinel)</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>value</b>: <span title="Codes:{http://cap.org/eCC 351601.100004300}">Exact number (specify)</span></p><p><b>derivedFrom</b>: <a href="Observation-observation-regional-lymph-node-status.html">Observation Regional Lymph Node Status</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:a903ae85-913a-4c9b-94cb-c6a1e00340e3"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="351602.100004300"/>
            <display
                     value="Total Number of Lymph Nodes Examined (sentinel and non-sentinel)"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectiveDateTime value="2025-03-18"/>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <valueCodeableConcept>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="351601.100004300"/>
            <display value="Exact number (specify)"/>
          </coding>
        </valueCodeableConcept>
        <derivedFrom>🔗 
          <reference
                     value="Observation/observation-regional-lymph-node-status"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-regional-lymph-nodes-number-sentinel"/>
    <resource>
      <Observation>
        <id value="observation-regional-lymph-nodes-number-sentinel"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-regional-lymph-nodes-number-sentinel"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-regional-lymph-nodes-number-sentinel</b></p><a name="observation-regional-lymph-nodes-number-sentinel"> </a><a name="hcobservation-regional-lymph-nodes-number-sentinel"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:25b43d87-bad0-4779-91c8-352ad2f778ce</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 351607.100004300}">Number of Sentinel Nodes Examined</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>value</b>: <span title="Codes:{http://cap.org/eCC 3351606.100004300}">Exact number (specify)</span></p><p><b>derivedFrom</b>: <a href="Observation-observation-regional-lymph-node-status.html">Observation Regional Lymph Node Status</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:25b43d87-bad0-4779-91c8-352ad2f778ce"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="351607.100004300"/>
            <display value="Number of Sentinel Nodes Examined"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectiveDateTime value="2025-03-18"/>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <valueCodeableConcept>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="3351606.100004300"/>
            <display value="Exact number (specify)"/>
          </coding>
        </valueCodeableConcept>
        <derivedFrom>🔗 
          <reference
                     value="Observation/observation-regional-lymph-node-status"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-distant-metastasis"/>
    <resource>
      <Observation>
        <id value="observation-distant-metastasis"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-distant-metastasis"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-distant-metastasis</b></p><a name="observation-distant-metastasis"> </a><a name="hcobservation-distant-metastasis"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem SECTION}">Section</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 352333.100004300}">DISTANT METASTASIS</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>hasMember</b>: <a href="Observation-observation-distant-metastasis-distant-sites.html">Observation Distant Site(s) Involved, if applicable</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="SECTION"/>
            <display value="Section"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="352333.100004300"/>
            <display value="DISTANT METASTASIS"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectiveDateTime value="2025-03-18"/>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <hasMember>🔗 
          <reference
                     value="Observation/observation-distant-metastasis-distant-sites"/>
        </hasMember>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-distant-metastasis-distant-sites"/>
    <resource>
      <Observation>
        <id value="observation-distant-metastasis-distant-sites"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-distant-metastasis-distant-sites"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-distant-metastasis-distant-sites</b></p><a name="observation-distant-metastasis-distant-sites"> </a><a name="hcobservation-distant-metastasis-distant-sites"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 352334.100004300}">Distant Site(s) Involved, if applicable</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>value</b>: <span title="Codes:{http://cap.org/eCC 352343.100004300}">Not applicable</span></p><p><b>derivedFrom</b>: <a href="Observation-observation-distant-metastasis.html">Observation DISTANT METASTASIS</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="352334.100004300"/>
            <display value="Distant Site(s) Involved, if applicable"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectiveDateTime value="2025-03-18"/>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <valueCodeableConcept>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="352343.100004300"/>
            <display value="Not applicable"/>
          </coding>
        </valueCodeableConcept>
        <derivedFrom>🔗 
          <reference value="Observation/observation-distant-metastasis"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-ptnm-classification-pT-Category"/>
    <resource>
      <Observation>
        <id value="observation-ptnm-classification-pT-Category"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-ptnm-classification-pT-Category"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-ptnm-classification-pT-Category</b></p><a name="observation-ptnm-classification-pT-Category"> </a><a name="hcobservation-ptnm-classification-pT-Category"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:4958b036-f88e-470b-b225-38e9fe6b6541</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 327740.100004300}">pT Category</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>value</b>: <span title="Codes:{http://cap.org/eCC 16736.100004300}">pT1b: Tumor greater than 5 mm but less than or equal to 10 mm in greatest dimension</span></p><p><b>derivedFrom</b>: <a href="Observation-observation-section-ptnm-classification.html">Observation PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition) (Note M)</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:4958b036-f88e-470b-b225-38e9fe6b6541"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="327740.100004300"/>
            <display value="pT Category"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectiveDateTime value="2025-03-18"/>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <valueCodeableConcept>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="16736.100004300"/>
            <display
                     value="pT1b: Tumor greater than 5 mm but less than or equal to 10 mm in greatest dimension"/>
          </coding>
        </valueCodeableConcept>
        <derivedFrom>🔗 
          <reference
                     value="Observation/observation-section-ptnm-classification"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-ptnm-classification-pN-Category"/>
    <resource>
      <Observation>
        <id value="observation-ptnm-classification-pN-Category"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-ptnm-classification-pN-Category"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-ptnm-classification-pN-Category</b></p><a name="observation-ptnm-classification-pN-Category"> </a><a name="hcobservation-ptnm-classification-pN-Category"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:7164b3a9-3061-4f7f-9bbb-2a4e6980d665</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 763178.100004300}">pN Category</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>value</b>: <span title="Codes:{http://cap.org/eCC 38649.100004300}">pN0: No regional lymph node metastasis identified or ITCs only#</span></p><p><b>derivedFrom</b>: <a href="Observation-observation-section-ptnm-classification.html">Observation PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition) (Note M)</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:7164b3a9-3061-4f7f-9bbb-2a4e6980d665"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="763178.100004300"/>
            <display value="pN Category"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectiveDateTime value="2025-03-18"/>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <valueCodeableConcept>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="38649.100004300"/>
            <display
                     value="pN0: No regional lymph node metastasis identified or ITCs only#"/>
          </coding>
        </valueCodeableConcept>
        <derivedFrom>🔗 
          <reference
                     value="Observation/observation-section-ptnm-classification"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-special-studies-breast-biomarker"/>
    <resource>
      <Observation>
        <id value="observation-special-studies-breast-biomarker"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-special-studies-breast-biomarker"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-special-studies-breast-biomarker</b></p><a name="observation-special-studies-breast-biomarker"> </a><a name="hcobservation-special-studies-breast-biomarker"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:3a313831-c8c5-44e7-8df2-af1b47b9879f</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 43789.100004300}">Breast Biomarker Testing Performed on Previous Biopsy</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>hasMember</b>: </p><ul><li><a href="Observation-observation-special-studies-estrogen-receptor.html">Observation Estrogen Receptor (ER)</a></li><li><a href="Observation-observation-special-studies-her2.html">Observation HER2 (by immunohistochemistry)</a></li></ul><p><b>derivedFrom</b>: <a href="Observation-observation-section-special-studies.html">Observation SPECIAL STUDIES</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:3a313831-c8c5-44e7-8df2-af1b47b9879f"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="43789.100004300"/>
            <display
                     value="Breast Biomarker Testing Performed on Previous Biopsy"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectiveDateTime value="2025-03-18"/>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <hasMember>🔗 
          <reference
                     value="Observation/observation-special-studies-estrogen-receptor"/>
        </hasMember>
        <hasMember>🔗 
          <reference value="Observation/observation-special-studies-her2"/>
        </hasMember>
        <derivedFrom>🔗 
          <reference value="Observation/observation-section-special-studies"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-special-studies-estrogen-receptor"/>
    <resource>
      <Observation>
        <id value="observation-special-studies-estrogen-receptor"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-special-studies-estrogen-receptor"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-special-studies-estrogen-receptor</b></p><a name="observation-special-studies-estrogen-receptor"> </a><a name="hcobservation-special-studies-estrogen-receptor"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:8e615e45-6a49-46d9-8dfe-e84f19c29a92</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 43789.100004300}">Estrogen Receptor (ER)</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-05</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>value</b>: <span title="Codes:{http://cap.org/eCC 50738}">Estrogen Receptor (ER)</span></p><p><b>hasMember</b>: <a href="Observation-observation-special-studies-estrogen-receptor-status.html">Observation Estrogen Receptor (ER) Status</a></p><p><b>derivedFrom</b>: <a href="Observation-observation-special-studies-breast-biomarker.html">Observation Breast Biomarker Testing Performed on Previous Biopsy</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:8e615e45-6a49-46d9-8dfe-e84f19c29a92"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="43789.100004300"/>
            <display value="Estrogen Receptor (ER)"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectiveDateTime value="2025-03-05"/>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <valueCodeableConcept>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="50738"/>
            <display value="Estrogen Receptor (ER)"/>
          </coding>
        </valueCodeableConcept>
        <hasMember>🔗 
          <reference
                     value="Observation/observation-special-studies-estrogen-receptor-status"/>
        </hasMember>
        <derivedFrom>🔗 
          <reference
                     value="Observation/observation-special-studies-breast-biomarker"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-special-studies-estrogen-receptor-status"/>
    <resource>
      <Observation>
        <id value="observation-special-studies-estrogen-receptor-status"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-special-studies-estrogen-receptor-status"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-special-studies-estrogen-receptor-status</b></p><a name="observation-special-studies-estrogen-receptor-status"> </a><a name="hcobservation-special-studies-estrogen-receptor-status"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:32bd9a78-878b-4fda-a6bd-c0bc58109fe7</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 45138.100004300}">Estrogen Receptor (ER) Status</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>value</b>: <span title="Codes:{http://cap.org/eCC 53472.100004300}">Cannot be determined (indeterminate)</span></p><p><b>derivedFrom</b>: <a href="Observation-observation-special-studies-estrogen-receptor.html">Observation Estrogen Receptor (ER)</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:32bd9a78-878b-4fda-a6bd-c0bc58109fe7"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="45138.100004300"/>
            <display value="Estrogen Receptor (ER) Status"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectiveDateTime value="2025-03-18"/>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <valueCodeableConcept>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="53472.100004300"/>
            <display value="Cannot be determined (indeterminate)"/>
          </coding>
        </valueCodeableConcept>
        <derivedFrom>🔗 
          <reference
                     value="Observation/observation-special-studies-estrogen-receptor"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-special-studies-her2"/>
    <resource>
      <Observation>
        <id value="observation-special-studies-her2"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-special-studies-her2"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-special-studies-her2</b></p><a name="observation-special-studies-her2"> </a><a name="hcobservation-special-studies-her2"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:deacb965-18d3-4451-a27f-0e26e7a9e5a2</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 79483}">HER2 (by immunohistochemistry)</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18</p><p><b>performer</b>: <a href="Practitioner-practitioner-pathologist.html">Practitioner Stains Alot </a></p><p><b>hasMember</b>: <a href="Observation-observation-special-studies-negative.html">Observation HER2 (by immunohistochemistry)</a></p><p><b>derivedFrom</b>: <a href="Observation-observation-special-studies-breast-biomarker.html">Observation Breast Biomarker Testing Performed on Previous Biopsy</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:deacb965-18d3-4451-a27f-0e26e7a9e5a2"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="79483"/>
            <display value="HER2 (by immunohistochemistry)"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectiveDateTime value="2025-03-18"/>
        <performer>🔗 
          <reference value="Practitioner/practitioner-pathologist"/>
        </performer>
        <hasMember>🔗 
          <reference
                     value="Observation/observation-special-studies-negative"/>
        </hasMember>
        <derivedFrom>🔗 
          <reference
                     value="Observation/observation-special-studies-breast-biomarker"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Observation/observation-special-studies-negative"/>
    <resource>
      <Observation>
        <id value="observation-special-studies-negative"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-observation"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Observation_observation-special-studies-negative"> </a><p class="res-header-id"><b>Generated Narrative: Observation observation-special-studies-negative</b></p><a name="observation-special-studies-negative"> </a><a name="hcobservation-special-studies-negative"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-observation.html">US Pathology Observation</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-CAPeCC.html" title="&quot;The College of American Pathologists (CAP) eCC (electronic Cancer Checklists) enables pathologists to use the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) directly within their laboratory information system (LIS) workflow and to ensure that each report is completed with the necessary required elements. Most anatomic pathology (AP)-LIS vendors offer a CAP eCC synoptic module for reporting on surgical cancer resections and selected biopsies.&quot;

&quot;The CAP eCC is based on the [CAP Cancer Protocols](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocols) and is produced under the guidance of the [CAP Pathology Electronic Reporting (PERT) Committee](https://www.cap.org/member-resources/councils-committees/pathology-electronic-reporting-pert-committee) along with close interaction and advisement of the [Cancer Committee](https://www.cap.org/member-resources/councils-committees/cancer-committee).

The eCC is developed in collaboration with and partially underwritten by the Centers for Disease Control and Prevention (CDC). Additional collaborators include the American Joint Committee on Cancer (AJCC), Cancer Care Ontario (CCO), and the North American Association of Central Cancer Registries (NAACCR).

The CAP currently is working with the [California Cancer Registry (CCR)](http://www.ccrcal.org/) to offer the benefits of the eCC to California laboratories. CCR and the CAP are seeking out laboratories interested in participating in an ongoing project using the eCC to directly transfer cancer data to the central registry.&quot;

&quot;The CAP releases eCC templates on a rolling basis, coordinating as much as possible with the posting of new and revised [Cancer Protocols and Cancer Biomarker Reporting Templates](https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates). A few weeks prior to each Major or Agile release, email notifications are sent out to all licensed CAP eCC users.&quot; For more information, see page [here](https://www.cap.org/laboratory-improvement/proficiency-testing/cap-ecc)">CAPeCC</a>/urn:uuid:1ca2fb51-1752-4489-a4b0-5c0dccc043e5</p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem QUESTION}">Question</span></p><p><b>code</b>: <span title="Codes:{http://cap.org/eCC 52399.100004300}">HER2 (by immunohistochemistry)</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>effective</b>: 2025-03-18</p><p><b>performer</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>value</b>: <span title="Codes:{http://cap.org/eCC 40505.100004300}">Negative (Score 0)</span></p><p><b>derivedFrom</b>: <a href="Observation-observation-special-studies-her2.html">Observation HER2 (by immunohistochemistry)</a></p></div>
        </text>
        <identifier>
          <system value="http://cap.org/eCC"/>
          <value value="urn:uuid:1ca2fb51-1752-4489-a4b0-5c0dccc043e5"/>
        </identifier>
        <status value="final"/>
        <category>
          <coding>
            <system
                    value="http://hl7.org/fhir/us/cancer-reporting/CodeSystem/us-pathology-codesystem"/>
            <code value="QUESTION"/>
            <display value="Question"/>
          </coding>
        </category>
        <code>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="52399.100004300"/>
            <display value="HER2 (by immunohistochemistry)"/>
          </coding>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <effectiveDateTime value="2025-03-18"/>
        <performer>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </performer>
        <valueCodeableConcept>
          <coding>
            <system value="http://cap.org/eCC"/>
            <code value="40505.100004300"/>
            <display value="Negative (Score 0)"/>
          </coding>
        </valueCodeableConcept>
        <derivedFrom>🔗 
          <reference value="Observation/observation-special-studies-her2"/>
        </derivedFrom>
      </Observation>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Specimen/specimen-breast"/>
    <resource>
      <Specimen>
        <id value="specimen-breast"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-specimen"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Specimen_specimen-breast"> </a><p class="res-header-id"><b>Generated Narrative: Specimen specimen-breast</b></p><a name="specimen-breast"> </a><a name="hcspecimen-breast"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-specimen.html">US Pathology Specimen</a></p></div><p><b>identifier</b>: <code>https://www.example.org/some-lis/fhir/specimen-identifier-provisioner</code>/987654321</p><p><b>accessionIdentifier</b>: <code>https://www.example.org/some-lis/fhir/specimen-identifier-provisioner</code>/987654321X</p><p><b>type</b>: <span title="Codes:{http://snomed.info/sct 119376003}">Tissue specimen (specimen)</span></p><p><b>request</b>: <a href="ServiceRequest-servicerequest-cancer-path.html">ServiceRequest Surgical pathology study</a></p><h3>Collections</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Collected[x]</b></td><td><b>Method</b></td><td><b>BodySite</b></td></tr><tr><td style="display: none">*</td><td>2025-03-18 17:00:14-0500</td><td><span title="Codes:{http://snomed.info/sct 65801008}">Excision (procedure)</span></td><td><span title="Codes:{http://snomed.info/sct 76752008}">Right breast, 8 o'clock, 4 cm from nipple</span></td></tr></table><h3>Containers</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Identifier</b></td><td><b>Type</b></td></tr><tr><td style="display: none">*</td><td><code>https://www.example.org/some-lis/fhir/specimen-containerID-provisioner</code>/123456789</td><td><span title="Codes:{http://snomed.info/sct 434711009}">Specimen container (physical object)</span></td></tr></table></div>
        </text>
        <identifier>
          <system
                  value="https://www.example.org/some-lis/fhir/specimen-identifier-provisioner"/>
          <value value="987654321"/>
        </identifier>
        <accessionIdentifier>
          <system
                  value="https://www.example.org/some-lis/fhir/specimen-identifier-provisioner"/>
          <value value="987654321X"/>
        </accessionIdentifier>
        <type>
          <coding>
            <system value="http://snomed.info/sct"/>
            <code value="119376003"/>
            <display value="Tissue specimen (specimen)"/>
          </coding>
        </type>
        <request>🔗 
          <reference value="ServiceRequest/servicerequest-cancer-path"/>
        </request>
        <collection>
          <collectedDateTime value="2025-03-18T17:00:14-05:00"/>
          <method>
            <coding>
              <system value="http://snomed.info/sct"/>
              <code value="65801008"/>
              <display value="Excision (procedure)"/>
            </coding>
          </method>
          <bodySite>
            <coding>
              <system value="http://snomed.info/sct"/>
              <code value="76752008"/>
              <display value="Breast structure (body structure)"/>
            </coding>
            <text value="Right breast, 8 o'clock, 4 cm from nipple"/>
          </bodySite>
        </collection>
        <container>
          <identifier>
            <system
                    value="https://www.example.org/some-lis/fhir/specimen-containerID-provisioner"/>
            <value value="123456789"/>
          </identifier>
          <type>
            <coding>
              <system value="http://snomed.info/sct"/>
              <code value="434711009"/>
              <display value="Specimen container (physical object)"/>
            </coding>
          </type>
        </container>
      </Specimen>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Patient/patient-OakleyAnnie"/>
    <resource>
      <Patient>
        <id value="patient-OakleyAnnie"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/core/StructureDefinition/us-core-patient"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Patient_patient-OakleyAnnie"> </a><p class="res-header-id"><b>Generated Narrative: Patient patient-OakleyAnnie</b></p><a name="patient-OakleyAnnie"> </a><a name="hcpatient-OakleyAnnie"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="http://hl7.org/fhir/us/core/STU6.1/StructureDefinition-us-core-patient.html">US Core Patient Profile</a></p></div><p style="border: 1px #661aff solid; background-color: #e6e6ff; padding: 10px;">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</p><hr/><table class="grid"><tr><td style="background-color: #f3f5da" title="Other Ids (see the one above)">Other Ids:</td><td colspan="3"><ul><li><a href="http://terminology.hl7.org/5.0.0/NamingSystem-CaliforniaDLN.html" title="California Motor Vehicle Bureau">CaliforniaDLN</a>/patient-OakleyAnnie</li><li>SHID/12446 (use: usual, )</li><li>FHIR/66574567 (use: usual, )</li></ul></td></tr><tr><td style="background-color: #f3f5da" title="Ways to contact the Patient">Contact Detail</td><td colspan="3"><ul><li>ph: 1-(303)555-1212(Home)</li><li><a href="mailto:annie.oakley@example.com">annie.oakley@example.com</a></li><li>4348 Main Street Denver CO 80111 US </li></ul></td></tr><tr><td style="background-color: #f3f5da" title="Patient Links">Links:</td><td colspan="3"><ul><li>Also see: <a href="RelatedPerson-relatedperson-pathology-next-of-kin.html">RelatedPerson Bill Hickok </a></li></ul></td></tr></table></div>
        </text>
        <identifier>
          <system value="urn:oid:2.16.840.1.113883.4.3.6"/>
          <value value="patient-OakleyAnnie"/>
        </identifier>
        <identifier>
          <use value="usual"/>
          <type>
            <text value="SHID"/>
          </type>
          <system value="https://www.example.org/hospital/smarthealthit"/>
          <value value="12446"/>
        </identifier>
        <identifier>
          <use value="usual"/>
          <type>
            <text value="FHIR"/>
          </type>
          <system
                  value="http://example.com/FHIR/StructureDefinition/patient-fhir-id"/>
          <value value="66574567"/>
        </identifier>
        <identifier>
          <use value="usual"/>
          <type>
            <text value="MRN"/>
          </type>
          <system value="urn:oid:2.16.840.1.113883.4.3.2"/>
          <value value="abc123"/>
        </identifier>
        <name>
          <family value="Oakley"/>
          <given value="Annie"/>
        </name>
        <telecom>
          <system value="phone"/>
          <value value="1-(303)555-1212"/>
          <use value="home"/>
        </telecom>
        <telecom>
          <system value="email"/>
          <value value="annie.oakley@example.com"/>
        </telecom>
        <gender value="female"/>
        <birthDate value="1990-06-01"/>
        <address>
          <line value="4348 Main Street"/>
          <city value="Denver"/>
          <state value="CO"/>
          <postalCode value="80111"/>
          <country value="US"/>
        </address>
        <link>
          <other>🔗 
            <reference
                       value="RelatedPerson/relatedperson-pathology-next-of-kin"/>
          </other>
          <type value="seealso"/>
        </link>
      </Patient>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Encounter/encounter-uspath-specimen-collection"/>
    <resource>
      <Encounter>
        <id value="encounter-uspath-specimen-collection"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/core/StructureDefinition/us-core-encounter|6.1.0"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Encounter_encounter-uspath-specimen-collection"> </a><p class="res-header-id"><b>Generated Narrative: Encounter encounter-uspath-specimen-collection</b></p><a name="encounter-uspath-specimen-collection"> </a><a name="hcencounter-uspath-specimen-collection"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="http://hl7.org/fhir/us/core/STU6.1/StructureDefinition-us-core-encounter.html">US Core Encounter Profileversion: null6.1.0)</a></p></div><p><b>identifier</b>: <code>http://example.com/fhir/encounters</code>/123</p><p><b>status</b>: Finished</p><p><b>class</b>: ActCode IMP: inpatient encounter (version = 3.0.0 )</p><p><b>type</b>: <span title="Codes:{http://snomed.info/sct 726007}">Pathology consultation, comprehensive, records and specimen with report</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>basedOn</b>: <a href="ServiceRequest-servicerequest-cancer-path.html">ServiceRequest Surgical pathology study</a></p><blockquote><p><b>participant</b></p><p><b>individual</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p></blockquote><blockquote><p><b>participant</b></p><p><b>individual</b>: <a href="Practitioner-practitioner-pathologist.html">Practitioner Stains Alot </a></p></blockquote></div>
        </text>
        <identifier>
          <system value="http://example.com/fhir/encounters"/>
          <value value="123"/>
        </identifier>
        <status value="finished"/>
        <class>
          <system value="http://terminology.hl7.org/CodeSystem/v3-ActCode"/>
          <version value="3.0.0"/>
          <code value="IMP"/>
          <display value="inpatient encounter"/>
        </class>
        <type>
          <coding>
            <system value="http://snomed.info/sct"/>
            <code value="726007"/>
            <display
                     value="Pathology consultation, comprehensive, records and specimen with report"/>
          </coding>
        </type>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <basedOn>🔗 
          <reference value="ServiceRequest/servicerequest-cancer-path"/>
        </basedOn>
        <participant>
          <individual>🔗 
            <reference value="Practitioner/practitioner-oncologist"/>
          </individual>
        </participant>
        <participant>
          <individual>🔗 
            <reference value="Practitioner/practitioner-pathologist"/>
          </individual>
        </participant>
      </Encounter>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/ServiceRequest/servicerequest-cancer-path"/>
    <resource>
      <ServiceRequest>
        <id value="servicerequest-cancer-path"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-service-request"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="ServiceRequest_servicerequest-cancer-path"> </a><p class="res-header-id"><b>Generated Narrative: ServiceRequest servicerequest-cancer-path</b></p><a name="servicerequest-cancer-path"> </a><a name="hcservicerequest-cancer-path"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-service-request.html">US Pathology Service Request</a></p></div><p><b>status</b>: Active</p><p><b>intent</b>: Order</p><p><b>category</b>: <span title="Codes:{http://snomed.info/sct 386053000}">Pathology</span></p><p><b>code</b>: <span title="Codes:{http://loinc.org 11529-5}">Surgical Pathology</span></p><p><b>subject</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>encounter</b>: <a href="Encounter-encounter-uspath-specimen-collection.html">Encounter: identifier = http://example.com/fhir/encounters#123; status = finished; class = inpatient encounter (ActCode[3.0.0]#IMP); type = Pathology consultation, comprehensive, records and specimen with report</a></p><p><b>occurrence</b>: 2025-03-18 17:00:14-0500</p><p><b>requester</b>: <a href="PractitionerRole-practitionerrole-uspath-surgeon.html">PractitionerRole Ordering Provider</a></p><p><b>specimen</b>: <a href="Specimen-specimen-breast.html">Specimen: identifier = https://www.example.org/some-lis/fhir/specimen-identifier-provisioner#987654321; accessionIdentifier = https://www.example.org/some-lis/fhir/specimen-identifier-provisioner#987654321X; type = Tissue specimen (specimen)</a></p></div>
        </text>
        <status value="active"/>
        <intent value="order"/>
        <category>
          <coding>
            <system value="http://snomed.info/sct"/>
            <code value="386053000"/>
            <display value="Evaluation procedure (procedure)"/>
          </coding>
          <text value="Pathology"/>
        </category>
        <code>
          <coding>
            <system value="http://loinc.org"/>
            <code value="11529-5"/>
            <display value="Surgical pathology study"/>
          </coding>
          <text value="Surgical Pathology"/>
        </code>
        <subject>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </subject>
        <encounter>🔗 
          <reference value="Encounter/encounter-uspath-specimen-collection"/>
        </encounter>
        <occurrenceDateTime value="2025-03-18T17:00:14-05:00"/>
        <requester>🔗 
          <reference
                     value="PractitionerRole/practitionerrole-uspath-surgeon"/>
        </requester>
        <specimen>🔗 
          <reference value="Specimen/specimen-breast"/>
        </specimen>
      </ServiceRequest>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/PractitionerRole/practitionerrole-uspath-practitioner-oncologist"/>
    <resource>
      <PractitionerRole>
        <id value="practitionerrole-uspath-practitioner-oncologist"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-related-practitioner-role"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="PractitionerRole_practitionerrole-uspath-practitioner-oncologist"> </a><p class="res-header-id"><b>Generated Narrative: PractitionerRole practitionerrole-uspath-practitioner-oncologist</b></p><a name="practitionerrole-uspath-practitioner-oncologist"> </a><a name="hcpractitionerrole-uspath-practitioner-oncologist"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-related-practitioner-role.html">US Pathology Related Practitioner Role</a></p></div><p><b>practitioner</b>: <a href="Practitioner-practitioner-oncologist.html">Practitioner Wise Owl </a></p><p><b>organization</b>: <a href="Organization-organization-Redwood-Womens-Center-PC.html">Organization Redwood Women's Center, P.C.</a></p><p><b>code</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/v2-0443 OP}">Ordering Provider</span></p><p><b>telecom</b>: ph: 720-242-5555</p></div>
        </text>
        <practitioner>🔗 
          <reference value="Practitioner/practitioner-oncologist"/>
        </practitioner>
        <organization>🔗 
          <reference
                     value="Organization/organization-Redwood-Womens-Center-PC"/>
        </organization>
        <code>
          <coding>
            <system value="http://terminology.hl7.org/CodeSystem/v2-0443"/>
            <version value="2.0.0"/>
            <code value="OP"/>
            <display value="Ordering Provider"/>
          </coding>
        </code>
        <telecom>
          <system value="phone"/>
          <value value="720-242-5555"/>
        </telecom>
      </PractitionerRole>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/PractitionerRole/practitionerrole-uspath-pathologist"/>
    <resource>
      <PractitionerRole>
        <id value="practitionerrole-uspath-pathologist"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-related-practitioner-role"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="PractitionerRole_practitionerrole-uspath-pathologist"> </a><p class="res-header-id"><b>Generated Narrative: PractitionerRole practitionerrole-uspath-pathologist</b></p><a name="practitionerrole-uspath-pathologist"> </a><a name="hcpractitionerrole-uspath-pathologist"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-related-practitioner-role.html">US Pathology Related Practitioner Role</a></p></div><p><b>practitioner</b>: <a href="Practitioner-practitioner-pathologist.html">Practitioner Stains Alot </a></p><p><b>organization</b>: <a href="Organization-organization-principal-pathology-lab.html">Organization Some Pathology Lab Name</a></p><p><b>code</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/v2-0443 PI}">Primary Interpreter</span></p><p><b>telecom</b>: ph: 720-242-9999</p></div>
        </text>
        <practitioner>🔗 
          <reference value="Practitioner/practitioner-pathologist"/>
        </practitioner>
        <organization>🔗 
          <reference
                     value="Organization/organization-principal-pathology-lab"/>
        </organization>
        <code>
          <coding>
            <system value="http://terminology.hl7.org/CodeSystem/v2-0443"/>
            <version value="2.0.0"/>
            <code value="PI"/>
            <display value="Primary Interpreter"/>
          </coding>
        </code>
        <telecom>
          <system value="phone"/>
          <value value="720-242-9999"/>
        </telecom>
      </PractitionerRole>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/PractitionerRole/practitionerrole-uspath-surgeon"/>
    <resource>
      <PractitionerRole>
        <id value="practitionerrole-uspath-surgeon"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/cancer-reporting/StructureDefinition/us-pathology-related-practitioner-role"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="PractitionerRole_practitionerrole-uspath-surgeon"> </a><p class="res-header-id"><b>Generated Narrative: PractitionerRole practitionerrole-uspath-surgeon</b></p><a name="practitionerrole-uspath-surgeon"> </a><a name="hcpractitionerrole-uspath-surgeon"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-us-pathology-related-practitioner-role.html">US Pathology Related Practitioner Role</a></p></div><p><b>practitioner</b>: <a href="Practitioner-practitioner-surgeon.html">Practitioner Cuts Alot </a></p><p><b>organization</b>: <a href="Organization-organization-Redwood-Womens-Center-PC.html">Organization Redwood Women's Center, P.C.</a></p><p><b>code</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/v2-0443 OP}">Ordering Provider</span></p><p><b>telecom</b>: ph: 720-242-5555</p></div>
        </text>
        <practitioner>🔗 
          <reference value="Practitioner/practitioner-surgeon"/>
        </practitioner>
        <organization>🔗 
          <reference
                     value="Organization/organization-Redwood-Womens-Center-PC"/>
        </organization>
        <code>
          <coding>
            <system value="http://terminology.hl7.org/CodeSystem/v2-0443"/>
            <version value="2.0.0"/>
            <code value="OP"/>
            <display value="Ordering Provider"/>
          </coding>
        </code>
        <telecom>
          <system value="phone"/>
          <value value="720-242-5555"/>
        </telecom>
      </PractitionerRole>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Organization/organization-Redwood-Womens-Center-PC"/>
    <resource>
      <Organization>
        <id value="organization-Redwood-Womens-Center-PC"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/core/StructureDefinition/us-core-organization"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Organization_organization-Redwood-Womens-Center-PC"> </a><p class="res-header-id"><b>Generated Narrative: Organization organization-Redwood-Womens-Center-PC</b></p><a name="organization-Redwood-Womens-Center-PC"> </a><a name="hcorganization-Redwood-Womens-Center-PC"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="http://hl7.org/fhir/us/core/STU6.1/StructureDefinition-us-core-organization.html">US Core Organization Profile</a></p></div><p><b>active</b>: true</p><p><b>name</b>: Redwood Women's Center, P.C.</p><p><b>address</b>: 3307 Renner Drive Fortuna CA 95540 USA </p></div>
        </text>
        <active value="true"/>
        <name value="Redwood Women's Center, P.C."/>
        <address>
          <line value="3307 Renner Drive"/>
          <city value="Fortuna"/>
          <state value="CA"/>
          <postalCode value="95540"/>
          <country value="USA"/>
        </address>
      </Organization>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Organization/organization-principal-pathology-lab"/>
    <resource>
      <Organization>
        <id value="organization-principal-pathology-lab"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/core/StructureDefinition/us-core-organization"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Organization_organization-principal-pathology-lab"> </a><p class="res-header-id"><b>Generated Narrative: Organization organization-principal-pathology-lab</b></p><a name="organization-principal-pathology-lab"> </a><a name="hcorganization-principal-pathology-lab"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="http://hl7.org/fhir/us/core/STU6.1/StructureDefinition-us-core-organization.html">US Core Organization Profile</a></p></div><p><b>active</b>: true</p><p><b>name</b>: Some Pathology Lab Name</p><p><b>address</b>: Any City CA 95540 USA </p></div>
        </text>
        <active value="true"/>
        <name value="Some Pathology Lab Name"/>
        <address>
          <line value="Any"/>
          <city value="City"/>
          <state value="CA"/>
          <postalCode value="95540"/>
          <country value="USA"/>
        </address>
      </Organization>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Practitioner/practitioner-pathologist"/>
    <resource>
      <Practitioner>
        <id value="practitioner-pathologist"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/core/StructureDefinition/us-core-practitioner"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Practitioner_practitioner-pathologist"> </a><p class="res-header-id"><b>Generated Narrative: Practitioner practitioner-pathologist</b></p><a name="practitioner-pathologist"> </a><a name="hcpractitioner-pathologist"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="http://hl7.org/fhir/us/core/STU6.1/StructureDefinition-us-core-practitioner.html">US Core Practitioner Profile</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-npi.html" title="National Provider Identifier">NPI</a>/1234567893</p><p><b>name</b>: Stains Alot </p></div>
        </text>
        <identifier>
          <system value="http://hl7.org/fhir/sid/us-npi"/>
          <value value="1234567893"/>
        </identifier>
        <name>
          <family value="Alot"/>
          <given value="Stains"/>
        </name>
      </Practitioner>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Practitioner/practitioner-oncologist"/>
    <resource>
      <Practitioner>
        <id value="practitioner-oncologist"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/core/StructureDefinition/us-core-practitioner"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Practitioner_practitioner-oncologist"> </a><p class="res-header-id"><b>Generated Narrative: Practitioner practitioner-oncologist</b></p><a name="practitioner-oncologist"> </a><a name="hcpractitioner-oncologist"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="http://hl7.org/fhir/us/core/STU6.1/StructureDefinition-us-core-practitioner.html">US Core Practitioner Profile</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-npi.html" title="National Provider Identifier">NPI</a>/1234567893</p><p><b>name</b>: Wise Owl </p></div>
        </text>
        <identifier>
          <system value="http://hl7.org/fhir/sid/us-npi"/>
          <value value="1234567893"/>
        </identifier>
        <name>
          <family value="Owl"/>
          <given value="Wise"/>
        </name>
      </Practitioner>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/Practitioner/practitioner-surgeon"/>
    <resource>
      <Practitioner>
        <id value="practitioner-surgeon"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/core/StructureDefinition/us-core-practitioner"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="Practitioner_practitioner-surgeon"> </a><p class="res-header-id"><b>Generated Narrative: Practitioner practitioner-surgeon</b></p><a name="practitioner-surgeon"> </a><a name="hcpractitioner-surgeon"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="http://hl7.org/fhir/us/core/STU6.1/StructureDefinition-us-core-practitioner.html">US Core Practitioner Profile</a></p></div><p><b>identifier</b>: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-npi.html" title="National Provider Identifier">NPI</a>/1234567893</p><p><b>name</b>: Cuts Alot </p></div>
        </text>
        <identifier>
          <system value="http://hl7.org/fhir/sid/us-npi"/>
          <value value="1234567893"/>
        </identifier>
        <name>
          <family value="Alot"/>
          <given value="Cuts"/>
        </name>
      </Practitioner>
    </resource>
  </entry>
  <entry>
    <fullUrl
             value="http://hl7.org/fhir/us/cancer-reporting/RelatedPerson/relatedperson-pathology-next-of-kin"/>
    <resource>
      <RelatedPerson>
        <id value="relatedperson-pathology-next-of-kin"/>
        <meta>
          <profile
                   value="http://hl7.org/fhir/us/core/StructureDefinition/us-core-relatedperson"/>
        </meta>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml"><a name="RelatedPerson_relatedperson-pathology-next-of-kin"> </a><p class="res-header-id"><b>Generated Narrative: RelatedPerson relatedperson-pathology-next-of-kin</b></p><a name="relatedperson-pathology-next-of-kin"> </a><a name="hcrelatedperson-pathology-next-of-kin"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="http://hl7.org/fhir/us/core/STU6.1/StructureDefinition-us-core-relatedperson.html">US Core RelatedPerson Profile</a></p></div><p><b>active</b>: true</p><p><b>patient</b>: <a href="Patient-patient-OakleyAnnie.html">Annie Oakley  Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))</a></p><p><b>relationship</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/v2-0131 N}">Next-of-Kin</span></p><p><b>name</b>: Bill Hickok </p><p><b>telecom</b>: ph: 1-989-654-7896</p></div>
        </text>
        <active value="true"/>
        <patient>🔗 
          <reference value="Patient/patient-OakleyAnnie"/>
        </patient>
        <relationship>
          <coding>
            <system value="http://terminology.hl7.org/CodeSystem/v2-0131"/>
            <code value="N"/>
            <display value="Next-of-Kin"/>
          </coding>
        </relationship>
        <name>
          <family value="Hickok"/>
          <given value="Bill"/>
        </name>
        <telecom>
          <system value="phone"/>
          <value value="1-989-654-7896"/>
        </telecom>
      </RelatedPerson>
    </resource>
  </entry>
</Bundle>